Clemson University

TigerPrints
All Dissertations

Dissertations

5-2016

Investigating the Role of ADP-forming Acetyl-CoA
Synthetase from the Protozoan Parasite Entamoeba
histolytica
Cheryl Page Jones
Clemson University, cherylh@g.clemson.edu

Follow this and additional works at: https://tigerprints.clemson.edu/all_dissertations
Recommended Citation
Jones, Cheryl Page, "Investigating the Role of ADP-forming Acetyl-CoA Synthetase from the Protozoan Parasite Entamoeba
histolytica" (2016). All Dissertations. 1668.
https://tigerprints.clemson.edu/all_dissertations/1668

This Dissertation is brought to you for free and open access by the Dissertations at TigerPrints. It has been accepted for inclusion in All Dissertations by
an authorized administrator of TigerPrints. For more information, please contact kokeefe@clemson.edu.

INVESTIGATING THE ROLE OF ADP-FORMING
ACETYL-COA SYNTHETASE FROM THE PROTOZOAN PARASITE
ENTAMOEBA HISTOLYTICA

A Dissertation
Presented to
the Graduate School of
Clemson University

In Partial Fulfillment
of the Requirements for the Degree
Doctor of Philosophy
Biochemistry and Molecular Biology

by
Cheryl Page Jones
May 2016

Accepted by
Dr. Cheryl Ingram-Smith, Committee Chair
Dr. William Marcotte, Jr.
Dr. Julia Frugoli
Dr. Kimberly Paul

ABSTRACT

ADP-forming acetyl-CoA synthetase (ACD; EC 6.2.1.13) catalyzes the reversible
conversion of acetyl-CoA to acetate coupled to the production of ATP. This enzyme is
present only in certain acetate-producing archaea and a limited number of bacteria and
eukaryotes. ACD belongs to the same NDP-forming acyl-CoA synthetase enzyme
superfamily as succinyl-CoA synthetase (SCS; EC 6.2.1.4) from the citric acid cycle, and
a similar three-step mechanism involving a phosphoenzyme intermediate was originally
proposed for this enzyme.
ACD has been postulated to be a major acetate-producing enzyme in the
protozoan parasite Entamoeba histolytica and may contribute to ATP production.
Biochemical and kinetic characterization of recombinant E. histolytica ACD (EhACD)
revealed that this enzyme may function in the direction of acetate production for
generation of ATP and CoA during growth in the high glucose environment of the small
intestine, and in acetate assimilation to acetyl-CoA in the high acetate environment of
the lower intestine during colonization. EhACD utilizes multiple substrates including
propionate and propionyl-CoA supporting an additional proposed role in amino acid
degradation. EhACD activity is regulated by both ATP and PPi, important energy
molecules in E. histolytica.
The ACD mechanism has been controversial, as a required second
phosphorylation step was proposed for the Pyrococcus furiosus enzyme. Investigation of
the catalytic role of the two proposed phosphorylation sites in EhACD revealed that
His252, the site of phosphorylation in the original three-step mechanism, is essential for
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activity and His533, the proposed second phosphorylation site, is important but not
essential. Likewise, Glu213, proposed to play a role in phosphorylation/
dephosphorylation of His252, is also required but Asp674 thought to stabilize the
phosphohistidine is not. These results suggest that EhACD follows a three-step
mechanism with a single phosphoenzyme intermediate.
Additional conserved active site residues were examined for their role in
catalysis. Asp314 was shown to be essential for activity, possibly in both a catalytic role
and a structural role. Alteration at this position resulted in complete loss of activity, and
computational modeling based on the Candidatus Korarchaeum cryptofilum ACD-I
structure suggests that this residue may be critical for dimerization. Future directions for
understanding the complex mechanism of ACD and its physiological role are presented.
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CHAPTER 1

LITERATURE REVIEW OF ACETATE METABOLISM, NDP-FORMING
ACYL-COA SYNTHETASE ENZYMES, AND ENTAMOEBA HISTOLYTICA

I.

INTRODUCTION

Acetate fermentation and assimilation are common processes in cellular
metabolism spanning all three domains of life. Acetate can be excreted as an end
product, utilized as a carbon source, and used for modification of proteins by acetylation.
The conversion between acetyl-CoA and acetate is an important cellular process that
can be catalyzed by multiple pathways. One such pathway utilizes a single enzyme,
ADP-forming acetyl-CoA synthetase (ACD; EC 6.2.1.13; Eq. 1), to reversibly catalyze
this reaction coupled to ATP hydrolysis or formation.
acetyl-CoA + ADP + Pi ßà acetate + ATP + CoA

[Eq. 1]

ACD is part of a superfamily of enzymes involved in the conversion of acyl-CoAs
to their corresponding acids. Biochemical and structural characterization of this family of
enzymes has focused on understanding the underlying mechanism. ACD is found in a
subset of protozoan parasites, including the amitochondriate Entamoeba histolytica
which causes amoebic dysentery and liver abscess. In this chapter, the common
pathways of acetate metabolism are introduced along with a thorough background of the
NDP-forming acyl-CoA synthetase family. Also, the metabolism of E. histolytica centered
around central carbon metabolism and energy generation is discussed.
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II.

ACETATE METABOLISM

Acetate is a common anion in biology and is a major metabolic end product in a
variety of organisms. When the incoming carbon flux surpasses the capacity of central
metabolic pathways, excess acetyl-CoA will undergo fermentation and recycle CoA. An
additional benefit of acetate fermentation is the generation of energy-containing
compounds such as ATP. The production of acetate is therefore considered an
“overflow” metabolism. Fermentation can also be a result of an incomplete or absent
TCA cycle. Anaerobic fermentation pathways are then used for the primary flow of
carbon (1).
Acetate assimilation as an alternative carbon source may occur under certain
conditions such as when glucose is diminished (1). Acetate is typically activated to form
acetyl-CoA, a central metabolic intermediate positioned at the junction of several
pathways. The high-energy thioester bond between the acetyl group and CoA can be
used to drive other reactions. Acetyl-CoA is also produced during the breakdown of
carbohydrates through glycolysis or breakdown of fatty acids via beta-oxidation.
Acetylation is a common post-translational modification of proteins involved in
regulating transcription and enzyme activity (2). Histone acetylation levels in the cell
have also been implicated as a method for maintaining intracellular pH (3). Acetate in its
protonated form (CH3COOH) will traverse the plasma membrane freely and ionize in the
neutral pH environment of the cell. Levels of free acetate within the cell must be
controlled or pH changes could be toxic.
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Acetate metabolism in archaea
Methane-producing archaea can be separated into CO2-reducing species and the
acetoclastic, or acetate-utilizing species. In the acetoclastic methanogens, consisting of
the genera Methanosaeta and Methanosarcina, the methyl group of acetate is converted
to methane and the carbonyl group to CO2 (4). However, Methanosarcina and
Methanosaeta use different strategies for acetate activation into acetyl-CoA.
Methanosarcina is the only archaeal genus containing a two enzyme pathway typical of
acetate-producing bacteria (5,6). Acetate is phosphorylated by ATP to form acetyl
phosphate via acetate kinase (ACK; EC 2.7.2.1; Eq. 2), and then acetyl phosphate is
converted to acetyl-CoA by phosphotransacetylase (PTA; EC 2.3.1.8; Eq. 3) (FIG 1.1A).
This pathway functions in reverse to regenerate CoA and serves as a source of ATP. It
is considered the ‘low affinity’ pathway that functions optimally when acetate
concentrations are ≥ 30 mM (7).
acetate + ATP ßà acetyl phosphate + ADP

[Eq. 2]

CoA + acetyl phosphate ßà acetyl-CoA + Pi

[Eq. 3]

Methanosaeta is able to accomplish acetate activation by a single enzyme,
AMP-forming acetyl-CoA synthetase (ACS; 6.2.1.1; Eq. 4) (8), which functions through a
bi-uni-uni-bi ping pong mechanism (7). ACS first binds acetate and ATP and forms the
enzyme-bound acetyladenylate (acetyl-AMP) intermediate and releases PPi (FIG 1.1B)
(9). Acetyl-AMP then reacts with CoA to form acetyl-CoA and release AMP. This
pathway is considered the ‘high affinity’ pathway preferring acetate concentrations below
10 mM (7). Both strategies for acetate activation require ATP consumption, and
consequently result in low energy output for the organism (4).
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FIG 1.1 Pathways for conversion of acetate to acetyl-CoA. (A) Low affinity pathway
involving acetate kinase and phosphotransacetylase, using an acetyl phosphate
intermediate. (B) High affinity pathway involving acetyl-CoA synthetase (AMP-forming)
which involves an enzyme-bound acyl-AMP intermediate. Obtained with permission from
(7).
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acetyl-CoA + AMP + PPi à acetate + ATP + CoA

[Eq. 4]

ACS is also found in several other archaeal organisms including Ignicoccus
hospitalis (10), Pyrobaculum aerophilum (11), and multiple halophilic species (12,13).
ACS serves as the primary acceptor in a novel CO2 fixation pathway within the
hyperthermophilic crenarchaeon I. hospitalis (10). Analysis of the Ignicoccus enzyme
revealed an unusual subcellular localization associated with the outermost membrane. In
contrast to the monomeric or dimeric forms in mesophilic species, ACS forms large
octameric complexes in Ignicoccus and another hyperthermophilic crenarchaeon P.
aerophilum (10,11). Most ACSs are limited to utilizing acetate as the acyl substrate,
however biochemical characterization from a few archaeal species revealed an
unexpected diversity in substrate utilization (11,14).
Investigation into acetate production and utilization in multiple halophilic species
revealed that ACS is responsible for the utilization of acetate, while ACD is responsible
for acetate formation when grown on glucose (12). Although the two enzymes both
catalyze interconversion of acetate and acetyl-CoA, they use very different mechanisms
and share no homology. ACS is widespread throughout the three domains of life; in
contrast, occurrence of ACD is limited.
ACD has been thoroughly studied in the anaerobic hyperthermophile Pyrococcus
furiosus (15-18). P. furiosus derives energy by carbohydrate and peptide fermentation
and contains several enzymes specialized to this type of metabolism (19). Pyruvate, the
end product of glycolysis, is converted to acetyl-CoA via the ferredoxin-dependent
enzyme pyruvate:ferredoxin oxidoreductase (PFOR; EC 1.2.7.1; Eq. 5).
pyruvate + CoA + ferredoxinox à acetyl-CoA + CO2 + ferredoxinred
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[Eq. 5]

Additional ferredoxin-dependent enzymes convert the peptide catabolism end products
(branched chain 2-keto acids, aromatic 2-keto acids, and 2-ketoglutarate) to their
corresponding CoA esters (19). ACD then utilizes these products to produce ATP. P.
furiosus contains two distinct ACD enzymes, classified as ACDI and ACDII, that vary in
their substrate specificity allowing this organism to utilize acetyl-CoA as well as the
branched chain acyl-CoAs and aryl-CoAs produced from peptide fermentation (19).
Upon further characterization, purified ACD from P. furiosus demonstrated reversible
activity, however there was no evidence for acetate utilization (17). ACDs from other
archaeal genera have also been investigated including Archaeoglobus (20,21),
Thermococcus (22), Haloarcula (23,24), Pyrobaculum (23), and Methanococcus (21).
Acetate metabolism in bacteria
Acetate production and utilization have been well studied in bacteria. Escherichia
coli produces acetate anaerobically via mixed-acid fermentation or aerobically during
rapid growth on glucose which causes inhibition of respiration. In contrast to the acetate
utilization pathway in Methanosarcina, the ACK-PTA pathway commonly functions in
acetate production in bacteria (FIG 1.2). The ACK-PTA pathway is also important for
maintaining correct concentrations of intracellular acetyl phosphate, which is an
important signaling molecule in many bacteria (25).
In Bifidobacteria and lactic acid bacteria, ACK partners with xylulose-5phosphate/ fructose-6-phosphate phosphoketolase (XFP; EC 4.1.2.9 [Eq. 6] and
4.1.2.22 [Eq. 7]) to produce acetate as part of a modified pentose phosphate pathway
(26).
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xylulose 5-phosphate + Pi à
acetyl phosphate + glyceraldehyde 3-phosphate + H2O

[Eq. 6]

fructose-6-phosphate + Pi à
acetyl phosphate + erythrose 4-phosphate + H2O

[Eq. 7]

Acetate can also be produced directly from pyruvate via a pyruvate oxidase, POXB (EC
1.2.5.1; Eq. 8). Oxidative decarboxylation of pyruvate coupled to the reduction of
ubiquinone produces acetate and CO2 (FIG 1.2). This reaction is postulated to provide
energy and acetyl groups under microaerophilic environments between the stationary
and growth phases (1,27).
pyruvate + ubiquinone + H2O à acetate + ubiquinol + CO2

[Eq. 8]

Bacteria can rapidly grow and excrete acetate, however when carbon resources
deplete, cells undergo a process called the “acetate switch” (1). Cells transition to a
phase of slower growth accompanied by uptake and utilization of acetate as an essential
carbon source. Recapture of acetate depends on activation of acetate by ACS (FIG 1.2).
This reaction is driven by the removal of pyrophosphate (PPi) by pyrophosphatase
(PPase; EC 3.6.1.1; Eq. 9).
PPi + H2O à 2 Pi

[Eq. 9]

Activity of ACS is post-translationally regulated by acetylation on a critical lysine residue
within the active site (28). Acetylation by a protein acetyltransferase inactivates ACS
(29), whereas activation takes place by deacetylation by the sirtuin CobB (30). This
regulation functions as a feedback system in which the activation of acetate is regulated
by energy (acetyl-CoA) and reducing equivalents (NAD+) (31). Salmonella enterica
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grown on low levels of acetate resulted in depletion of ATP and growth arrest when
regulation of ACS was disrupted (31). Consequently, tight regulation of ACS is
necessary for proper energy balance within the cell.
The sole bacterial ACD characterized to date comes from the photoheterotrophic
bacterium Chloroflexus aurantiacus (32), which lacks the PTA-ACK pathway to produce
acetate. ACD was induced over 10-fold in C. aurantiacus during growth on glucose,
suggesting it partners with glycolysis. Additional putative ACD homologs have been
identified in other bacterial genomes, particularly from acetate-forming syntrophic
bacteria lacking genes for PTA and ACK, suggesting ACD may serve as an alternative
for acetate production (33,34).
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FIG 1.2 Pathways of acetate metabolism in E. coli (A) acAMP = acetyl-AMP; acCoA =
acetyl-CoA; AckA = acetate kinase; acP = acetyl P; Acs = acetyl-CoA synthetase; CoA =
coenzyme A; Pi = inorganic phosphate; PPi =pyrophosphate; PPase = pyrophosphatase;
Pta =phosphotransacetylase. (B) Carbon flux and associated pathways during growth on
glucose. GS = glyoxylate shunt; TCA = tricarboxylic acid cycle; PoxB = pyruvate
oxidase; ICL = isocitrate lyase; IclR = repressor of the glyoxylate shunt operon aceBAK;
FadR = regulator of fatty acid metabolism that also activates iclR. Taken with permission
for reuse from (35).
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Acetate metabolism in eukaryotes
ACS is central to the metabolism of almost all eukaryotic cells to activate acetate
to acetyl-CoA (7). Eukaryotes usually have two isoforms, one localized to the
mitochondria and another localized to the cytosol (36,37), although additional evidence
suggests the cytosolic enzyme also resides with the nucleus (38). The mitochondrial
enzyme is essential for maintaining energy homeostasis during ketogenic conditions in
mammals (37), such as fasting or diabetes mellitus, when the liver releases large
amounts of acetate into the bloodstream (39-41). The cytosolic isoform is associated
with fatty acid synthesis, particularly supporting tumorogenesis (42), and has been of
interest in understanding metabolism of tumor cells under hypoxic conditions (43). This
isoform was also shown to be essential for yeast replicative longevity and predicted to
produce acetyl-CoA within the nucleus for histone acetylation (38). ACS located within
the plastid of Arabidopsis was suggested to recycle acetate as a toxic breakdown
product of other fermentation pathways (44). In humans, endogenous sources of acetate
that can be recycled via ACS include the breakdown of the neurotransmitter
acetylcholine by acetylcholinesterase, deacetylation of histones in the nucleus, and
catabolism of ethanol in the liver (45). Large concentrations of acetate are also produced
by the gut microbiota which serve as a primary carbon source for adjacent intestinal
cells, where glucose is limiting (46).
Regulation of ACS by reversible acetylation as found in bacteria is also
conserved in the human enzymes (47). NAD+-dependent deacetylases known as sirtuins
are responsible for activation of ACS by deacetylation (28), but the acetyltransferase
responsible for acetylation has yet to be identified. Sirtuins are known for regulating

10

gene silencing, energy homeostasis, and aging, suggesting a link between acetate
metabolism and the aging process (45).
One ACS isoform is essential for growth of the fungal pathogen Candida albicans
on a variety of carbon sources (48). De novo fatty acid synthesis via cytosolic ACS is
essential in the bloodstream form of the parasite, Trypanasoma brucei (49). ACS was
also recently identified in the cytosol of the protozoan parasite, Leishmania donovanii
(50).
ACK was originally thought to be only a bacterial enzyme with the exception of
the Methanosarcina genus of archaea, however it has now been identified in several
eukaryotic species (51). The ACK-PTA pathway is found in the green algae
Chlamydomonas reinhardtii (52) and the oomycete Phytophthora ramorum (51,53). C.
reinhardtii contains two ACK/PTA pathways (54) that are differentially localized to the
chloroplast and the mitochondria and function primarily for acetate production under
dark, anoxic conditions (52).
In euascomycete and basidiomycete fungi, ACK partners with one or more XFP
enzymes as part of a modified pentose phosphate pathway using xylulose-5-phosphate
or fructose-6-phosphate as substrates (51). The only eukaryotic XFP to be characterized
is from the pathogenic fungus Cryptococcus neoformans. This enzyme, one of two XFPs
in C. neoformans, has been found to be allosterically regulated (55). A unique PPidependent ACK [Eq. 10] in Entamoeba histolytica converts acetyl phosphate to acetate
and PPi (56). ACK activity has been detected in extracts of E. histolytica trophozoites,
which suggests the enzyme is present under normal growth conditions. However, the
source of the acetyl phosphate substrate is currently unknown as no known partner
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enzymes are present within the genome. The hypothesized function is to provide PPi for
glycolysis, but its role remains a mystery.
Acetyl phosphate + Pi à acetate + PPi

[Eq. 10]

Fungi can also produce acetate from pyruvate through a pyruvate
dehydrogenase bypass pathway composed of pyruvate decarboxylase (PDC; EC
4.1.1.1; Eq. 11) and acetaldehyde dehydrogenase (ALD; EC 1.2.1.5; Eq. 12). A deletion
of two ALD genes in Saccharomyces cerevisiae decreased acetate formation during
anaerobic growth on glucose, demonstrating a major role in acetate production (57).
PDC is thought to occupy the branch point between oxidative metabolism through the
TCA cycle and fermentative metabolism (58).
pyruvate à acetaldehyde + CO2

[Eq. 11]

acetaldehyde + NAD(P)+ + H2O à acetate + NAD(P)H

[Eq. 12]

Eukaryotic ACD is limited to a few protozoan parasites, having been positively
identified in Giardia lamblia (59) and E. histolytica (60), and putative acd genes have
been identified in the genome sequences of Plasmodium falciparum and
Cryptosporidium muris, corroborating the idea the ACD plays a role in the parasitic
lifestyle. Like E. histolytica, G. lamblia is an amitochondriate protozoan parasite that
relies on substrate-level phosphorylation for energy generation (61).
Acetate:succinate CoA transferase (ASCT; EC 2.8.3.8; Eq. 13) is present in
hydrogenosomes of Trichomonas vaginalis (62), and mitochondria of Trypanasomatidae
(63,64) and the parasitic helminth Fasciola hepatica (65). It functions by transferring CoA
from acetyl-CoA to succinate, forming succinyl-CoA. This enzyme works in conjunction
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with succinyl-CoA synthetase in order to produce ATP (Eq. 14). As for ACD, this
specialized enzyme involved in acetate metabolism is associated with a few parasitic
organisms, indicating the special role acetate metabolism can play in the parasitic
lifestyle.
acetyl-CoA + succinate à succinyl-CoA + acetate

[Eq. 13]

succinyl-CoA + ADP + Pi à succinate + CoA + ATP

[Eq. 14]

Acetyl-CoA hydrolase (ACH; EC 3.1.2.1; Eq. 15) hydrolyzes acetyl-CoA,
producing acetate and CoA. This reaction is not energy-conserving considering the highenergy thioester bond is cleaved to only low-energy products. ACH is proposed to
function by aiding transfer of acetyl units between subcellular compartments (66).
acetyl-CoA + H2O à acetate + CoA

[Eq. 15]

In summary, several pathways exist for both production and utilization of acetate.
The three main pathways (ACK/PTA, ACS, and ACD) are each found within all three
domains of life. The balance between these two processes is tightly regulated in order to
maintain proper carbon metabolism.
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III.

NDP-FORMING ACYL-COA SYNTHETASES

A newly recognized superfamily of NDP-forming acyl-CoA synthetases was
identified by Sanchez et al. in 2000 (67). This family is comprised of several metabolic
enzymes that either utilize NTP to generate an acyl-CoA molecule, or vice versa, use the
cleavage of the thioester bond to generate an NTP (FIG 1.3A). Members of this enzyme
family contain five subdomains – two CoA ligase domains, two ATP grasp domains, and
a CoA binding domain. As the name suggests, the CoA binding domain is the location of
the CoA binding pocket. The two ATP grasp domains form a cleft capable of opening
and closing due to nucleotide binding, making these enzymes also part of the ATP-grasp
family (68). The arrangement of these subdomains is unique between family members
(FIG 1.3B), yet remarkably the overall mechanism remains the same.
Some members of this family have independent alpha and beta subunits that
come together as a heteromer, while in other members the enzyme functions as a
homodimer with fused alpha and beta subunits connected by a hinge region. Although
both types usually maintain a similar quaternary structure, the significance of the hinge
region has not been studied. Catalysis proceeds through a common mechanism
involving a phosphoenzyme intermediate. The active site is separated into two regions,
designated Site I and Site II, where different parts of the reaction take place (69). The
NTP binds within the cleft of the two ATP-grasp domains within Site II and
phosphorylates N-3 of the imidazole ring of the active site histidine (located within
subdomain 2). The phosphoryl moiety is then transferred to the acyl substrate within Site
I, forming a transient acyl-phosphate intermediate that transfers the acyl group to CoA.
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The catalytic His residue is conserved throughout the entire superfamily with the
exception of the acetyltransferases (67). Specific members of the superfamily will be
discussed in the following sections.
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FIG 1.3 NDP-forming acyl-CoA synthetases. (A) Schematic of the general mechanism
for this superfamily of enzymes. Green and red arrows indicate products/substrates in
opposite directions of the reaction. (B) Domain organization of various enzymes within
the superfamily. Gray connecting bars indicate a hinge region.
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Succinyl-CoA synthetase
Succinyl-CoA synthetase (SCS; EC 6.2.1.4 and 6.2.1.5) is the most well-studied
member of this superfamily of enzymes. Present in almost all organisms, SCS catalyzes
the sole substrate-level phosphorylation reaction in the citric acid cycle. SCS functions
as a thiolase, coupling cleavage of the thioester bond in succinyl-CoA to phosphorylation
of a nucleoside diphosphate [Eq 16].
succinyl-CoA + ADP/GDP + Pi ßà succinate + CoA + ATP/GTP [Eq 16]
SCS functions as a heterotetramer composed of two alpha and two beta subunits
(70-72). The structures of SCS enzymes from E. coli (73), pig heart (74), and Thermus
aquaticus (71) have been determined to date. The first structure of SCS from E. coli was
determined by X-ray crystallography in 1994 (73) and revealed phosphorylation of a His
residue (His246) located on a loop region within the alpha subunit. The CoA bound to
the alpha subunit was positioned with the free thiol oriented near the active site His.
Since the nucleoside was shown to bind 30 Å away on the beta subunit (75), Fraser et
al. (76) hypothesized that the loop containing the phosphorylated His swings between
Site I within the alpha subunit to Site II within the beta subunit in order to accomplish a
phosphoryl transfer to the nucleotide.
Structural characterization of pig heart SCS with the catalytic alpha His in both
the dephosphorylated and phosphorylated states further supported this mechanism (74).
In addition to the catalytic His residue, two Glu residues were implicated to stabilize the
phosphorylated His intermediate in E. coli SCS (77). The carboxylate group of Glu208α
interacts with the catalytic His at Site I by accepting a hydrogen bond at N1on the
imidazole ring. This Glu residue also stabilizes the proton on N1 of the imidazole ring
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when it is not phosphorylated. Glu197β has been hypothesized to function in a similar
manner when the phosphorylated His moves to Site II and dephosphorylates.
While generally specific for succinyl-CoA, SCS varies in NDP specificity. E. coli
SCS can use both ADP and GDP substrates but prefers ADP (78). T. aquaticus SCS
can also use both ADP and GDP but prefers GDP (71). Mammals possess two isoforms
of SCS, one specific for GDP and the other specific for ADP, that are present in different
tissues (79,80). The nucleotide binding site was determined to be located within the beta
subunit between the two ATP grasp subdomains (76). Analysis of the open and closed
GTP-bound structures of pig heart SCS revealed a Gln residue located within the NDP
binding pocket that interacts with the guanine base (81). That same position is replaced
by Pro in both E. coli and T. aquaticus SCSs (71,75). However, a Glu residue within the
binding pocket of the T. aquaticus SCS is replaced by Ala, allowing an additional water
molecule to bind between the Pro and the guanine base (71).This interaction mimics that
of the Gln residue in GTP-specific pig heart SCS and determines the preference for
GDP.
ATP citrate lyase
ATP citrate lyase (ACL; EC 2.3.3.8) utilizes ATP hydrolysis in order to convert
citrate to cytosolic acetyl-CoA and oxaloacetate(OAA) [Eq. 17]. First identified in rat liver
in 1971 (82), this enzyme has been studied in multiple eukaryotic organisms including
human (83-87), rat (88), fungi (89), yeast (90), plants (91), and green algae (92).
Prokaryotic ACL has only been identified in autotrophic bacteria and archaea containing
a reductive TCA cycle as a CO2 assimilation pathway (90,93,94) and in sulfur-dependent
archaea (95). This enzyme represents the link between cytosolic carbohydrate
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metabolism and production of fatty acids. Characterization thus far suggests that ACL
functions solely as a citrate lyase and does not catalyze the reverse citrate synthase
activity (96).
citrate + ATP + CoA + H2O à OAA + acetyl-CoA + ADP + Pi

[Eq. 17]

Knockdown of ACL in mammalian cells impairs glucose-dependent lipid synthesis,
increases mitochondrial membrane potential, and decreases cell proliferation (97). ACL
is required for normal growth and development in plants, resulting in a bonsai-phenotype
of small stature and organ size when knocked down in Arabidopsis (98). ACL has been
implicated in tumorigenesis (99) and has been suggested as a potential target for
chemotherapeutic agents (100).
ACL consists of an N-terminal region composed of the five subdomains present
in all NDP-forming acyl-CoA synthetases and a C-terminal region containing a citrate
synthase domain (FIG 1.3B). ACL from the yeast Rhodotorula gracilis and bacterium
Chlorobium tepidum were shown to be homotetramers (90,93). In the 1980's, attempts to
purify and characterize ACL were complicated by the varying levels of phosphorylation
observed. The enzyme is phosphorylated on serine and threonine residues (101,102)
and this phosphorylation is regulated by hormones glucagon, insulin, and vasopressin in
rats (101) and varies depending on tissue localization (101). Two protein kinases
capable of phosphorylating ACL were identified (102,103). ATP citrate lyase kinase
phosphorylates Thr446 and Ser454 of the human enzyme, while cAMP-dependent
protein kinase phosphorylates Ser454. These residues are located within the hinge
region between subdomains 5 and 1 (83). In vitro phosphorylation of recombinant
bacterial ACL by protein kinase A increased maximal activity 3- to 6-fold (87). Potapova
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et al. (87) suggested that phosphorylation only occurs on one of the four subunits, and a
conformational change prevents phosphorylation on the remaining subunits.
The enzyme also responds to positive allosteric regulation by phosphorylated
sugars, particularly fructose-6-phosphate (87). The increase in overall activity is most
dramatic in the unphosphorylated enzyme. The presence of fructose-6-phosphate also
caused a large reduction in Km values for ATP and citrate, suggesting a conformational
change that affects the binding sites of these two substrates. ACL from Chlorobium
limicola consists of separate alpha and beta subunits encoded by neighboring genes,
and lacks the region of phosphorylation (96).
NTP substrate preference varies among ACLs. Hydrogenobacter thermophilus
prefers ATP, but can utilize GTP at a lower rate (94). However, C. tepidum and C.
limicola enzymes can only utilize ATP (93,96). Mammalian enzymes can bind GTP, but
only utilize ATP for catalysis (104). Inhibition by ADP was first observed for the H.
thermophilus ACL(94). Recombinant ACL from C. limicola was shown to be
competitively inhibited by the presence of ADP (96,104).
Kinetics analysis of ACL purified from rat liver indicate a double displacement
mechanism involving a phosphoenzyme intermediate is the most likely mechanism (88).
Like other NDP-forming acyl-CoA synthetases, the mechanism is believed to proceed
through a catalytic phosphohistidine analogous to the Hisα of SCS. Mutagenesis of
His765 in human ACL abolished enzymatic activity, supporting the role of this residue as
the critical phosphorylated intermediate. This was further confirmed with recombinant
ACL from C. limicola in which alteration of the catalytic His residue to Ala resulted in
complete loss of activity (105). Phosphorylation of the catalytic His residue in the
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absence of citrate and CoA was still observed but at a much lower rate (~1%). However,
phosphorylation of a His760Ala variant suggests there may be a second unproductive
phosphorylation site located within the active site. The first ACL crystal structure was of
a truncated version of the human enzyme (83). Structural analysis revealed the citrate
binding site is located within subdomain 2 along with the supposed nucleotide binding
site in subdomains 3 and 4, similar to E. coli SCS (FIG 1.3B). The enzyme was then
crystallized with Mg2+-ADP bound revealing the nucleotide binding site within the ATP
grasp domains (106).
Acetyl-CoA synthetase
ADP-forming acetyl-CoA synthetases (ACD; EC 6.2.1.13; Eq. 1) are not
widespread and are found primarily in acetate-producing archaea (17,18,107) and a few
eukaryotic (59,108) and bacterial species (32). ACDs have been designated as either
ACDI or ACDII based on substrate specificity. ACDI primarily reacts with acetyl-CoA
while ACDII is capable of functioning on branched-chain acyl-CoAs or aryl-CoAs. As
discussed previously, they catalyze the reversible conversion of acetyl-CoA to acetate,
forming ATP via substrate level phosphorylation. Structural characterization was limited
until recently when ACD1 from Candidatus Korarchaeum cryptofilum was crystallized
under several conditions (69). ACD will be discussed further in later chapters.
Additional enzymes
Malyl-CoA synthetase (EC 6.2.1.9) catalyzes a reaction similar to that of SCS
and is composed of the same arrangement of subdomains. Malate is converted to malylCoA as part of glyoxylate and dicarboxylate metabolism (109). Recombinant enzyme
from Pseudomonas was purified and characterized, revealing a heterotetramer formation
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of alpha-beta dimers (110). Mechanistic studies with [γ-32P]ATP indicated a “half-of-thesites” reactivity, meaning that only one active site was phosphorylated at a time (111).
Pimeloyl-CoA synthetase (EC 6.2.1.14) from Pseudomonas mendocina was
originally reported as an AMP-forming enzyme (112); however, the original assay did not
differentiate between AMP and ADP formation. Sequence analysis revealed strong
similarity to the NDP-forming acyl-CoA synthetases as opposed to AMP forming
enzymes, indicating pimeloyl-CoA synthetase is likely a member of this enzyme
superfamily (67). Pimeloyl-CoA is the first intermediate in the biotin synthesis pathway.
Recombinant pimeloyl-CoA synthetase from P. mendocina formed a tetrameric enzyme
and exhibited typical Michaelis-Menten kinetics (112).
E. coli PatZ (formerly YfiQ) and Salmonella enterica Pat are protein
acetyltransferases with significant homology to ACD. Each of the five subdomains of the
NDP-forming acyl-CoA synthetase family is present in the same order as in ACD, along
with a GCN5-related N-acetyltransferase domain (FIG 1.3B). PatZ is the only known
acetyltransferase in E. coli and its function is to regulate AMP-forming acetyl-CoA
synthetase by acetylation (113). The biochemical and kinetic characterization of S.
enterica PAT revealed the enzyme exists as a monomer but forms a tetramer upon
acetyl-CoA binding (114). E. coli PatZ demonstrated autoacetylation that changed the
oligomerization from a tetramer to a more stable and more active octamer (115). The
acetyltransferase proteins lack the primary catalytic His residue found in the rest of the
superfamily, and instead that position contains an asparagine residue incapable of being
phosphorylated.
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Although some biochemical, functional, and structural analysis of this superfamily
of enzymes has been accomplished already, many questions remain. The origin of
domain shuffling is still a mystery, along with the division of enzymes as either separate
subunits or fusions.
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IV.

ENTAMOEBA HISTOLYTICA

Entamoeba histolytica is a protozoan parasite responsible for amoebic colitis
(dysentery) and liver abscess in humans. An estimated 500 million people are infected
each year, with 50 million developing colitis and liver abscess, causing 40,000 – 100,000
deaths every year (116-118). It is the second leading cause of death by parasitic disease
worldwide and is endemic to areas of Central and South America, Asia, Africa, and the
Pacific Islands (116). E. histolytica cycles between two life stages: an infectious cyst and
vegetative trophozoite (FIG 1.4). The environmentally-resistant cyst is typically ingested
via contaminated food or water. The cyst passes through the digestive system into the
small intestine where it undergoes excystation. Trophozoites then migrate to the large
intestine and multiply via binary fission. E. histolytica typically maintains an
asymptomatic infection in the colon, however it can break through the intestinal epithelial
lining and travel through the bloodstream to other organs. Infection of the liver results in
substantial tissue damage, leading to abscess and death. Some trophozoites undergo
encystation in the colon and are expelled in order to continue transmission. Cysts are
highly resistant to disinfectants and can persist for months outside the host in moist
environments (119).
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FIG 1.4 Life cycle of Entamoeba histolytica. The parasite cycles between the
infectious cyst stage and the vegetative trophozoite that colonizes the human large
intestine. Obtained from Wikimedia commons (File: Entamoebahistolyticalifecycleen.svg)

25

Virulence and treatment
The colon is lined with a thick layer of mucin separating the intestinal microbiota
from host epithelial cells. Adherence to this layer is essential for infection and is
mediated by surface lectins that bind galactose (Gal) and N-acetyl-D-galactosamine
(GalNAc) oligosaccharides (120). E. histolytica virulence is facilitated by contactdependent cytotoxicity (121) and secreted proteins. Ingestion of microbes and host cells
can occur via phagocytosis (122,123) or trogocytosis (124), and the resulting cellular
material is degraded by a variety of enzymes within the phagolysosome (125).
The primary line of defense against invasive amoebiasis is metronidazole and
other nitroimidazole derivatives (126). Originally discovered for the treatment of
Trichomonas vaginalis infections, metronidazole targets anaerobic organisms. Upon
entering the cell, metronidazole is reduced on the nitro group by reduced ferredoxin into
short-lived cytotoxic intermediates (127,128). These compounds cause DNA strand
breakage, eventually leading to disrupted transcription and cell death. Two
pharmacokinetics studies showed 42% and 76% penetration of the drug into the colonic
mucosa (129,130). Although largely effective, metronidazole has limitations because
only 90% of patients respond to treatment, and parasites persist in 40-60% of treated
patients (126). A second-line treatment of paromomycin or diloxanide furoate is
necessary to completely clear infection (126). Furthermore, resistance to metronidazole
has been demonstrated in vitro (131,132). Although this has not been observed
clinically, the possibility is of growing concern. Efforts to develop new therapeutic targets
as well as potential vaccines are currently underway (133-135).
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Metabolism depends on the environment
E. histolytica possesses a uniquely reduced metabolism compared to typical
eukaryotes, lacking mitochondria and several biosynthetic pathways (136).
Consequently, the parasite relies heavily on scavenging essential nutrients including
most amino acids, nucleic acids, lipids, and vitamins. Carbohydrate metabolism depends
on availability within the environment. Trophozoites first emerge within the small
intestine where glucose is prevalent and glycolysis is thought to provide the majority of
energy for E. histolytica (137). However, as E. histolytica travels to the colon, the
concentration of glucose is very low (138). Glucose transporters of epithelial cells in the
small intestine have high affinity for glucose and most is removed before nutrients reach
the colon (139). Consequently, the parasite must adapt to long-term glucose starvation
in order to survive (140). Glucose starvation has been known to trigger cyst formation in
other amoeboid species (141-143). Furthermore, Entamoeba competes with prevalent
intestinal flora for nutrients (144). It has been suggested that E. histolytica secretes a
beta-amylase enzyme to break down mucin oligosaccharides as a source of
carbohydrates (145). In contrast, when E. histolytica invades the blood (146) or liver
tissue (147), exogenous glucose is abundant, but the parasite must deal with other
stresses. Also present in the colon are high concentrations of short-chain fatty acids,
including acetate, that are known to be taken up in pH dependent manner by a related
Entamoeba species (148).
Glycolysis
E. histolytica has several adaptations within its glycolytic pathway. The ATPdependent phosphofructokinase (PFK; EC 2.7.9.1; Eq. 18) has been replaced by a
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pyrophosphate (PPi)-dependent phosphofructokinase (PPi-PFK; 2.7.1.90; Eq. 19). PFK
is typically an important point of regulation within glycolysis due to its irreversibility and
allosteric regulation by AMP. However, PPi-PFK is not allosterically regulated and
constitutes a reversible reaction under physiological conditions (149-151).
Fructose-6-phosphate + ATP à fructose-1,6-bisphosphate + ADP [Eq. 18]
Fructose-6-phosphate + PPi ßà fructose-1,6-bisphosphate + Pi [Eq. 19]
Pyruvate phosphate dikinase (PPDK; EC 2.7.9.1; Eq. 20) is another PPi-dependent
enzyme which catalyzes the reversible conversion of phosphoenolpyruvate (PEP) to
pyruvate replacing the typical pyruvate kinase (PK; 2.7.1.40; Eq. 21) (152).
PEP + AMP + PPi ßà pyruvate + ATP + Pi

[Eq. 20]

PEP + ADP ßà pyruvate + ATP

[Eq. 21]

A potential benefit of using PPi is the conservation of energy from PPi-generating
anabolic reactions. Also, since the typical “committed step” is now reversible under
physiological conditions, these enzymes could be involved in both catabolic and anabolic
processes (153). Another atypical glycolytic enzyme of unknown significance is the
GDP-dependent phosphoglycerate kinase (GDP-PGK; EC 2.7.2.10), which displays a
significant preference for GDP over ADP as the phosphoryl acceptor (154).
While these adaptations may confer an advantage to Entamoeba, they also
require a change in the typical regulation of glycolysis. Each glycolytic enzyme of E.
histolytica has been studied recombinantly (150,155). Elasticity analysis was used to
understand how central carbon metabolism is regulated in live trophozoites of E.
histolytica. The initial steps of hexose transporter, hexokinase, and glycogen
degradation were determined to be the controlling steps (156).

28

As first observed by electron microscopy in 1970 (157), Entamoeba cells contain
numerous glycogen granules in the cytoplasm. The high glycogen content observed
when cells are cultured under high glucose serves as an energy reservoir that is capable
of supporting glycolysis for up to 2 hours after glucose starvation before a significant
decrease in ATP output or cell viability (156). Glycogen granules and the enzymes for
their synthesis and degradation have all been characterized (158,159).
Most organisms employ the allosterically regulated pyruvate dehydrogenase
complex to couple the conversion of pyruvate to acetyl-CoA and concomitantly produce
NADH. However, multiple amitochondriate protozoan species lack a pyruvate
dehydrogenase complex and instead complete the pyruvate to acetyl-CoA reaction via
oxidative decarboxylation by pyruvate:ferrodoxin oxidoreductase (PFOR; EC 1.2.7.1).
PFOR uses the cofactor ferredoxin as an electron acceptor to complete this reaction.
This enzyme is typically found in Archaea, but has been identified in E. histolytica and G.
lamblia. Both PFOR and ACD are thought to have been acquired by lateral gene transfer
(160). EhPFOR has been studied in cell extracts (161).
Amino acid metabolism
E. histolytica lacks de novo synthesis pathways for the majority of amino acids.
Consequently, it relies on scavenging in order to supply its amino acid requirements.
Furthermore, the parasite is also capable of taking up amino acids to use them for
energy generation (160,162). During glucose starvation, glycolysis-related genes are
downregulated and amino acid consumption increases (162). Asparagine, aspartate,
serine, alanine, tryptophan, cysteine, threonine, methionine, glutamine and glutamate
can all be converted into either pyruvate or a 2-oxoacid (160). PFOR converts pyruvate
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or 2-oxoacids to CoA esters, from which ACD can produce ATP and the corresponding
acids.
Aspartate and asparagine are taken up in the presence or absence of glucose
(162). Under long-term glucose shortage, methionine gamma-lyase and aspartate
ammonia lyase are upregulated (163). Aspartate ammonia lyase converts aspartate to
fumarate and ammonia, and asparaginase converts asparagine to aspartate and
ammonia. Methionine gamma-lyase, a unique enzyme found only in E. histolytica and
Trichomonas vaginalis, is capable of breaking down methionine or the potentially toxic
homocysteine (160) to produce ammonia and 2-oxobutanoate. Flux analysis performed
by Pineda et al. (156) indicated that amino acid catabolism cannot substitute for glucose
to maintain ATP levels. However, the lack of a sufficient number of replicates brings
these conclusions into question.
E. histolytica is capable of synthesizing just two amino acids, serine and
cysteine. Cysteine serves a special role in E. histolytica in combatting oxidative stress.
Typical eukaryotes contain glutathione as a low-molecular weight thiol capable of
maintaining redox balance. However, E. histolytica does not contain glutathione and
utilizes cysteine in this role instead (164). Cysteine has been deemed essential for
growth, motility, adherence, and demonstrated protection against oxidative stress in vitro
(165,166). Cysteine synthesis is critical to the parasite (167) and occurs via a two-step
pathway from serine (168). Serine acetyltransferase (EC 2.3.1.30) converts serine to Oacetylserine by transferring the acetyl moiety from acetyl-CoA. Cysteine synthase (EC
4.2.99.8) then generates cysteine from O-acetylserine and sulfhydryl, releasing acetate.
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This pathway is one source of excreted acetate, in addition to the pathways discussed
later in this chapter.
Mitosome
Most eukaryotic organisms contain mitochondria that primarily function in ATP
generation via oxidative phosphorylation and the electron transport chain. Several
parasitic protozoan species do not have fully functional mitochondria (169), but instead
retain highly reduced mitochondrion-related organelles (MROs). The principal functions
of mitochondria have likely been lost due to adaptation to an anaerobic lifestyle. For
some of these parasites such as T. vaginalis, this MRO is known as a hydrogenosome
which produces molecular hydrogen and ATP (170). E. histolytica and G. lamblia
possess the most degenerate MRO, known as a mitosome (170). Fe-S cluster synthesis
was thought to be the solely retained function of mitosomes. However, the system found
in E. histolytica does not originate from mitochondria but is found in nitrogen-fixing
bacteria. Furthermore, the localization of this system in either the mitosome or cytosol is
currently debated. However, a unique sulfate activation has been localized to the
mitosome in E. histolytica (171,172). Investigations revealed that this sulfate activation
pathway plays a role in proliferation (172) and encystation (173).
Excreted products
E. histolytica excretes three compounds during growth in vitro: acetate, ethanol,
and alanine (160). The definitive function of alanine secretion is unknown, however it is
thought to be a mechanism for eliminating excess nitrogen. Ethanol is produced via a
bifunctional alcohol/acetaldehyde dehydrogenase(ADHE; E.C. 1.2.1.10, 1.1.1.1) enzyme
that first converts acetyl-CoA to acetaldehyde and then to ethanol, regenerating a
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molecule of NAD+ at each step (174). There are three potential sources of excreted
acetate: 1) as a byproduct of cysteine synthesis via cysteine synthase, 2) during
additional ATP production via ADP-forming acetyl-CoA synthesis, or 3) by acetate
kinase (FIG 1.5). The relative contributions of each of these pathways to acetate
production is unknown.
E. histolytica possesses a unique PPi-producing acetate kinase, and as
discussed previously in this chapter, there is no known partner enzyme present in the
genome (51,56,175). The source of the acetyl phosphate substrate has been postulated
to come from ingested bacteria (175). The role of this enzyme remains to be determined,
however, characterization of the recombinant enzyme indicates it functions primarily in
PPi and acetate formation. It is possible that PPi is produced in order to supply the
unique PPi-dependent enzymes in glycolysis or that PPi is used as a regulatory
compound.
The balance between acetate and ethanol production is influenced by
environmental oxygen concentrations. The first observations under anaerobic growth
conditions indicated a ratio of ethanol:acetate production of 2:1 (176). This balance was
then reversed to a 2:1 acetate:ethanol ratio under aerobic conditions. However, both of
these observations were measured during monoxenic growth and the relative
contributions from bacteria cannot be determined. Once axenic culture protocols were
established, E. histolytica excretion was once again studied. Under aerobic growth,
acetate was the major metabolite produced (60). After exposure to supraphysiological O2
concentrations, E. histolytica showed a reduction in ethanol production and an increase
in acetate production during the recovery period compared to unstressed cells (161).
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PFOR and ADHE were both drastically inhibited by reactive oxygen species. Pineda et
al. performed metabolic control analysis to understand the acetate and ethanol flux
under moderate aerobic conditions, mimicking the environment encountered when
invades tissue adjacent to the colon (177). They observed that PFOR and ADHE were
major points of regulation of central carbon metabolism. The reported output of ethanol
and acetate under typical in vitro growth conditions was 26 ± 7 and 3.6 ± 8 nmol min-1
mg-1 cell protein, respectively.
Recent knockdown of ACD in E. histolytica trophozoites revealed a significant
reduction in acetate production in culture (178). Contributions to ATP were negligible,
but ACD was shown to be important for maintaining acetyl-CoA/CoA homeostasis,
especially under oxidative stress conditions when ADHE was inhibited. Knockdown of
ACK showed no reduction in acetate production and no conclusions about the function
of ACK could be made.
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FIG 1.5 Acetate metabolism in E. histolytica. ACD = ADP-forming acetyl-CoA
synthetase; SAT = serine acetyltransferase; CS = cysteine synthase; ACK = acetate
kinase.
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V.

CONCLUSIONS

In summary, acetate metabolism is clearly an important process in many
organisms, including parasitic protozoans. Both acetate production and assimilation
occur under different conditions depending on the enzymes present and the cell’s needs.
ADP-forming acetyl-CoA synthetase functions in acetate metabolism and is part of a
superfamily of NDP-forming acyl-CoA synthetases that catalyze a set of reactions
involved in central carbon metabolism and often are involved in energy homeostasis.
The metabolism of the amitochondriate parasite Entamoeba histolytica is severely
limited, however an ACD enzyme is present. The research presented in the following
chapters will explore the function and mechanism of EhACD.
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BIOCHEMICAL AND KINETIC CHARACTERIZATION OF THE RECOMBINANT
ADP-FORMING ACETYL-COA SYNTHETASE FROM THE AMITOCHONDRIATE
PROTOZOAN ENTAMOEBA HISTOLYTICA

Cheryl P. Jones and Cheryl Ingram-Smith

I.

ABSTRACT

Entamoeba histolytica, an amitochondriate protozoan parasite that relies on
glycolysis as a key pathway for ATP generation, has developed an unique extended PPidependent glycolytic pathway in which ADP-forming acetyl-CoA synthetase (ACD;
Acetate:CoA ligase (ADP-forming) [EC 6.2.1.13]) converts acetyl-CoA to acetate to
produce additional ATP and recycle CoA. We have characterized the recombinant E.
histolytica ACD and have shown that the enzyme is bidirectional, allowing it to potentially
play a role in ATP production or in utilization of acetate. In the acetate-forming direction,
acetyl-CoA is the preferred substrate and propionyl-CoA was used with lower efficiency.
In the acetyl-CoA forming direction, acetate is the preferred substrate, with a lower
efficiency observed with propionate. The enzyme can utilize both ADP/ATP and
GDP/GTP in the respective directions of the reaction. ATP and PPi were found to inhibit
the acetate-forming direction of the reaction with IC50 values of 0.81 ± 0.17 mM and 0.75
± 0.20 mM, respectively, which are both in the range of their physiological
concentrations. ATP and PPi displayed mixed inhibition versus each of the three
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substrates, acetyl-CoA, ADP, and phosphate. This is the first example of regulation of
ACD enzymatic activity, and possible roles for this are discussed.

Citation: Jones, C. P., and Ingram-Smith, C. (2014) Biochemical and kinetic
characterization of the recombinant ADP-forming acetyl coenzyme A synthetase from
the amitochondriate protozoan Entamoeba histolytica. Eukaryotic Cell 13, 1530-1537.
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II.

INTRODUCTION

Entamoeba histolytica, a protozoan parasite that causes amoebic dysentery and
amoebic liver abscess in humans, is a leading cause of morbidity and mortality due to
parasitic disease worldwide, second only to malaria (1).This parasite has a two-stage life
cycle, existing as infectious cysts or motile trophozoites that can reside in the anaerobic
confines of the human colon and cause disease. After ingestion of cysts and excystation
to release trophozoites, asymptomatic infection can occur when trophozoites remain
confined to the intestine. However, the parasite can break through the epithelial lining of
the intestine and enter the bloodstream, resulting in an invasive infection. Cell lysis,
phagocytosis, and trogocytosis all play a role in pathogenicity and contribute sources of
nutrients to this metabolically limited parasite (2).
E. histolytica lacks a functional TCA cycle and oxidative phosphorylation, and
consequently relies on substrate-level phosphorylation to provide high-energy
compounds. This amitochondriate protozoan utilizes an unusual PPi-dependent
glycolytic pathway (FIG 2.1) in which ATP-dependent phosphofructokinase is replaced
by PPi-dependent phosphofructokinase, and pyruvate kinase is replaced by a PPidependent pyruvate phosphate dikinase (3-5). The pyruvate end-product of glycolysis is
converted to acetyl-CoA by pyruvate:ferredoxin oxidoreductase (PFOR) rather than
pyruvate dehydrogenase. Acetyl-CoA can then be broken down to ethanol by a
bifunctional aldehyde-alcohol dehydrogenase (ADHE) (6) or to acetate by ADP-forming
acetyl-CoA synthetase (ACD; Acetate:CoA ligase (ADP-forming); EC 6.2.1.13) [Eq. 1].
acetyl-CoA + ADP + Pi D acetate + CoA + ATP
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[Eq. 1]

FIG 2.1 The PPi-dependent extended glycolytic pathway of E. histolytica. Relevant
steps that produce or utilize ATP and PPi are shown, and enzymes that catalyze
reactions specific to this pathway are indicated. Dotted arrows represent multiple steps
that are not shown. Abbreviations: PPi-PFK, pyrophosphate-dependent
phosphofructokinase; PPDK, pyruvate phosphate dikinase; PFOR, pyruvate:ferredoxin
oxidoreductase; ACD, ADP-forming acetyl-CoA synthetase; ADHE, bifunctional
aldehyde-alcohol dehydrogenase.
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This extended PPi-dependent glycolytic pathway increases ATP output per glucose
molecule to three when ethanol is produced and to five when acetate is the product.
ACD was first identified as an acetate-forming activity in E. histolytica extracts, and the
partially purified enzyme was shown to have activity in both directions of the reaction (7).
The only other characterized eukaryotic ACD is that from the amitochondriate Giardia
lamblia (8-10), for which only substantial acetate-forming activity was detected (10).
Although not widespread, ACD has been identified in all three domains and is
postulated for the conversion of acetyl-CoA to acetate. In archaea, ACD was first
identified in Pyrococcus furiosus (11,12), a thermophilic anaerobe that ferments
carbohydrates and peptides, and has now been identified in a number of other archaea,
including the thermophilic anaerobes Pyrococcus woesei, Desulfurococcus amylolyticus,
Hyperthermus butylicus, and Thermococcus celer (13,14), the hyperthermophilic
anaerobic sulfate reducer Archaeoglobus fulgidus (15), and the halophilic aerobe
Halobacterium saccharovorum (13,14). Native ACD has been purified from P. furiosus
(11,12) and Haloarcula marismortui (16), and recombinant ACDs from P. furiosus (17),
A. fulgidus (18), Methanococcus jannaschii (18), H. marismortui (16), Pyrobaculum
aerophilum (16), and Thermococcus kodakarensis (19) have been characterized.
A similar role for ACD in acetate production has been proposed in bacteria. Most
bacteria have phosphotransacetylase (PTA) and acetate kinase (ACK), which form a
predominant pathway for acetate production from acetyl-CoA. ACD from the
phototrophic Chloroflexus aurantiacus has recently been purified and the recombinant
enzyme characterized (20). The syntrophs Pelotomaculum thermopropionicum (21) and
Syntrophus aciditrophicus (22), and the propionic acid producing Propionibacterium
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acidipropionici (23) all lack genes for the PTA-ACK pathway and instead have acd
genes. ACD has been identified in proteome analysis of P. acidipropionici cells grown
under acetate-producing conditions, but the enzyme has not been purified or
characterized (23). Likewise, the acetate-producing archaea listed above that have ACD
lack genes encoding the PTA-ACK pathway.
ACD is part of a superfamily of nucleoside diphosphate-forming acyl-CoA
synthetases, which includes the closely related citric acid cycle enzyme succinyl-CoA
synthetase (SCS; EC 6.2.1.4) as well as ATP citrate lyase (EC 2.3.3.8) and malate
thiokinase (EC 6.3.1.9) (9). SCS has been extensively studied kinetically and structurally
(24-26), and a three-step enzymatic mechanism has been proposed (27) [Steps 1-3]:
Step 1:

succinyl-CoA + Pi D E~succinyl-P + CoA

Step 2:

E~succinyl-P D E-His~P + succinate

Step 3:

E-His~P + ADP D ATP

Based on their studies with P. furiosus ACD, Brasen et al. (28) proposed that ACD
proceeds through a mechanism similar to that of SCS, but with an additional step in
which the phosphoryl group is transferred from a His residue on the α subunit to a His
residue on the β subunit before transfer to ADP in the final step to produce ATP.
Here we report the biochemical and kinetic characterization of the recombinantly
produced ACD from the intestinal parasite E. histolytica, revealing its ability to function in
either acetate production or utilization in vitro. Our results confirm that both the acetylCoA forming and acetate-forming activities of ACD are present in cell lysate from E.
histolytica trophozoites. Inhibition studies suggest E. histolytica ACD (EhACD) is
regulated through inhibition by ATP and PPi in the acetate-forming direction.
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III.

MATERIALS AND METHODS

Materials
Chemicals were purchased from Sigma-Aldrich, VWR International, Gold
Biotechnology, Fisher Scientific, Atlanta Biological, Life Technologies, and J R Scientific.
Growth of E. histolytica trophozoites and preparation of cell lysate
E. histolytica strain HM-1:IMSS (kindly provided by Dr. Lesly Temesvari,
Clemson University) was cultured axenically at 37°C in TYI-S-33 medium (29). Cells
were harvested by incubation on ice for 10 minutes and centrifugation at ~350 x g for 5
minutes at 4°C. The pellet was resuspended in 0.8 ml lysis buffer (50 mM Tris-HCl [pH
7.3], 1 mM AEBSF, 0.015 mM E-64, 0.02 mM Pepstatin A, 5 mM 1,10-Phenanthroline)
and disrupted by five cycles of freezing in a dry ice/ethanol bath and thawing at 37°C.
The cell lysate was kept on ice, and enzymatic activity was assayed immediately using
the DTNB and hydroxamate assays described below. Total protein concentration was
determined using the Bradford method (30) with bovine serum albumin as standard.
Production and purification of E. histolytica ACD
A codon-optimized E. histolytica acd gene was synthesized by Genscript and
cloned into pET21b (Novagen) for production of recombinant E. histolytica ACD in
Escherichia coli. The pET21b-ACD plasmid was transformed into E. coli
Rosetta2(DE3)pLysS cells (Novagen) and cultures were grown in Luria-Bertani medium
(LB) containing 50 µg ml-1 ampicillin and 34 µg ml-1 chloramphenicol shaking at 200 rpm
at 37°C to A600 ~0.8. Protein production was initiated by the addition of isopropyl β-D-1thiogalactopyranoside (IPTG) to a final concentration of 0.5 mM. Cultures were grown
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overnight at ambient temperature and harvested by centrifugation. Cells were
suspended in ice-cold buffer A (25 mM Tris-HCl, 150 mM NaCl, 10% glycerol, 20 mM
imidazole [pH 7.4]) and disrupted by two passages through a French pressure cell at
138 MPa. The cell lysate was clarified via ultracentrifugation at ~ 98,000 x g for 1 hour at
4°C, and cell-free extract was applied to a 5 ml HisTrap HP nickel affinity column (GE
Healthcare) equilibrated with buffer A. After extensive washing with buffer A to remove
unbound protein, the column was developed with a linear gradient from 0 to 0.5M
imidazole in buffer A. Fractions containing active enzyme were pooled, dialyzed
overnight in buffer (25 mM Tris-HCl, 10% glycerol, [pH 7.0]), aliquoted, and stored at 80°C. The enzyme was judged to be electrophoretically pure by SDS-PAGE analysis.
Protein concentration was determined from the absorbance at 280 nm using the Take3
Micro-volume plate (BioTek).
Determination of molecular mass
The native molecular mass of EhACD was determined by gel filtration
chromatography through a Superose 12 column (GE Healthcare) pre-equilibrated with
50 mM Tris-HCl, 150 mM NaCl [pH 7.0]. The column was calibrated with cytochrome C
(12.4 kDa), carbonic anhydrase (29 kDa), albumin (66 kDa), amylase (200 kDa),
apoferritin (443 kDa), and thyroglobulin (669 kDa), and developed at a flow rate of 0.5 ml
per minute.
Determination of kinetic parameters for EhACD
Pseudo-first order reaction kinetics determinations were performed in both
directions of the reactions. Enzymatic activity in the acetate-forming direction was
determined by measuring the release of CoASH from acyl-CoA using Ellman’s thiol
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reagent (5,5'-dithio-bis-[2-nitrobenzoic acid], DTNB) (31). Production of NTB2- by CoASH
cleavage of DTNB was measured spectrophotometrically at 412 nm. Reaction mixtures
(50 mM Tris-HCl, 0.3 mM DTNB, 6 mM HEPES (used to solubilize DTNB) [pH 7.3]) with
varied substrate concentrations were pre-incubated at 37°C for 5.5 minutes. Assays
were performed in 96-well plates in 0.2 ml reaction volumes. Reactions were initiated by
the addition of enzyme, and absorbance was measured every 4 seconds at 37°C using a
Synergy HT Multi-Mode Microplate Reader (BioTek). Initial velocities were converted to
µmol CoASH formed using an extinction coefficient of ε = 13.6 mM-1 cm-1 for the
thiophenolate NTB2- anion. One unit of activity is defined as 1 μmol product per minute
per mg protein. In determination of kinetic parameters for acetate formation, non-varied
substrate concentrations were held at 0.3 mM acetyl-CoA, 8 mM KH2PO4, and 5 mM
MgCl2:ADP or 6 mM MgCl2:GDP. For propionate formation, non-varied substrate
concentrations were held at 0.3 mM propionyl-CoA, 12.5 mM KH2PO4, and 3 mM
MgCl2:ADP.
Activity in the acetate-forming direction was confirmed using the
hexokinase/glucose-6-phosphate dehydrogenase coupled assay (32). This assay
couples ATP formation to the reduction of NADP+ to NADPH, which is measured
spectrophotometrically at 340 nm. Reaction mixtures (100 mM Tris-HCl [pH 7.3], 5.5 mM
glucose, 1 mM NADP+, 0.2 mM DTT) with varied concentrations of substrates were preincubated at 37°C for 5.5 minutes, hexokinase and glucose-6-phosphate dehydrogenase
were added, and the reactions were initiated by the addition of ACD. Assays were
performed in 96-well plates in 0.2 ml reaction volumes and absorbance was measured
every 4 seconds at 37°C using a Synergy HT Multi-Mode Microplate Reader (BioTek).
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Initial velocities were converted to μmol ATP formed using an extinction coefficient ε =
6.22 mM-1 cm-1 for NADPH. Concentrations of non-varied substrate used for both the
DTNB assay and coupled enzyme assay were identical.
Enzymatic activity for detection of acetyl-CoA formation was determined using
the hydroxamate assay (33,34). Reaction mixtures (50 mM Tris-HCl [pH 7.5], 300 mM
hydroxylamine-HCl [pH 7.0]) with varied substrate concentrations were pre-incubated at
37°C for 5.5 minutes and reactions were initiated by the addition of enzyme. Reactions
(0.15 ml) were terminated by the addition of one volume of stop solution (2.5% FeCl3,2 N
HCl,10% trichloroacetic acid) and the absorbance at 540 nm was measured. Product
formation was determined by comparison to an acetyl-CoA standard curve. For acyl
substrates prepared in ethanol, the final concentration of ethanol in the reaction was
kept to 2.5%, which was determined not to affect enzymatic activity. One unit of activity
is defined as 1 mmol of acetyl-CoA produced per minute per mg protein. In determination
of kinetic parameters for acetyl-CoA formation, the non-varied substrates were held at
100 mM acetate, 1 mM CoA, 20 mM MgCl2:ATP, and 25 mM MgCl2:GTP. For
determination of kinetic parameters for propionyl-CoA formation, the non-varied
substrates were held at the following concentrations: 250 mM propionate, 3 mM CoA,
and 20 mM MgCl2:ATP.
Apparent kinetic parameters were determined by varying the concentration of a
single substrate while the concentrations of the other two substrates were held constant.
For determination of the apparent steady-state kinetic parameters Km, kcat, and kcat/Km
and their standard deviations, nonlinear regression in KaleidaGraph (Synergy Software)
was used to fit the data to the Michaelis-Menten equation.
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Determination of inhibition parameters
Various metabolic intermediates were tested as effectors of ACD. IC50 values
(the effector concentration that provides half maximal inhibition) for inhibitors were
determined at Km substrate concentrations by measuring the decrease in enzymatic
activity as a function of increasing concentrations of inhibitor. Non-linear regression
analysis in GraphPad Prism 5 (GraphPad Software) was used to fit the data to the log
[inhibitor] vs. response curve to determine IC50 values. To examine the mode of
inhibition, enzymatic activity was assayed in each direction in a four-by-four matrix of
varied inhibitor concentrations versus varied concentrations of one substrate, with the
other two substrates held constant. Linear regression in KaleidaGraph (Synergy
Software) was used to resolve the point of intersection of the inverse plots.
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IV.

RESULTS

General characterization
The limited characterization of partially purified native E. histolytica ACD reported
by Reeves et al. (7) indicated the enzyme has a narrow nucleotide specificity. To allow a
more thorough characterization of the E. histolytica ACD (EhACD), we produced the
recombinant enzyme in E. coli. A codon-optimized gene was synthesized by Genscript
and cloned into the pET21b E. coli expression vector (Novagen), which encodes for
addition of a C-terminal His6 tag to the recombinant protein. The calculated subunit
molecular mass of the recombinant His-tagged protein is 78999 Da. The molecular mass
of the purified enzyme was estimated to be ~150 kDa by gel filtration chromatography,
suggesting EhACD is dimeric as for the G. lamblia ACD (10). The optimum temperature
for ACD activity was determined to be 55°C in the acetyl-CoA forming direction but could
not be determined in the acetate-forming direction due to limitations of the equipment
used for measurements. This unexpectedly high optimal temperature may be an artifact
from the assay conditions or represent unusual stability of this protein, but was not
analyzed further. However, activity was routinely assayed at 37°C, the temperature E.
histolytica trophozoites would typically encounter within the human host. The enzyme
had approximately 70% activity at this temperature versus its optimum temperature.
The requirement for a divalent cation was examined and ACD was found to have
the highest activity with Mg2+ and Mn2+ and substantial activity with Co2+ in both
directions of the reaction, but only weak activity with Ni2+, Zn2+, Ca2+, and Cu2+ (FIG 2.2).
The preference for Mg2+, Mn2+, and Co2+ is similar to that of other ACDs (10,11,18).
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FIG 2.2 Divalent cation specificity of EhACD. Activities were determined in each
direction of the reaction using saturating substrate conditions in the presence or absence
of metals (3 mM final concentration in the acetate-forming direction and 20 mM final
concentration in the acetyl-CoA forming direction). Activities are normalized to the
activity observed with Mg2+. Black bars: activity in the acetate-forming direction. Gray
bars: activity in the acetyl-CoA forming direction. Activities are the mean ± SD of three
replicates.
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ACD enzymatic activity was observed in both directions of the reaction, and the
reaction rate was linearly dependent on enzyme concentration. Specific activity in the
acetate-forming direction (85 ± 1.2 µmol min-1 mg-1) was approximately half that
observed in the acetyl-CoA forming direction (180 ± 2.0 μmol min-1 mg-1). Similarly,
measurement of ACD specific activity in E. histolytica cell extract showed that activity in
the acetate-forming direction was approximately half that in the acetyl-CoA forming
direction (0.14 ± 0.022 μmol min-1 mg-1 versus 0.29 ± 0.004 μmol min-1 mg-1). In contrast,
ACD activity in Giardia cell extracts could only be detected in the direction of acetate
formation (10). Although the purified recombinant Giardia ACD had activity in both
directions of the reaction, the acetyl-CoA forming activity was ~4% of the acetateforming activity (9).
EhACD has a limited acyl-CoA substrate range, with the highest activity
observed with acetyl-CoA and lower activity observed with propionyl-CoA (16 ± 2.8%
activity versus that with acetyl-CoA). Less than 1% activity was observed with isobutyrylCoA and isovaleryl-CoA at 0.3 mM final concentration, and no activity was observed with
butyryl-CoA, succinyl-CoA, or phenylacetyl-CoA. ADP and GDP gave the highest activity
(100 ± 1.0% and 106 ± 3.7% activity, respectively), although activity was also observed
with IDP (28 ± 3.8%), CDP (7.0 ± 0.2%), and UDP (2.8 ± 0.1%); no activity was
observed with TDP as substrate. PPi was tested with AMP as the phosphoryl acceptor
but no activity was observed under the conditions tested.
In the acyl-CoA forming direction, acetate was the favored substrate, and
propionate and butyrate could also be used with relative activities of 72 ± 1.5%, and 5.6
± 0.2%, respectively, versus acetate. Less than 4% activity was observed with
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isobutyrate, valerate, isovalerate, hexanoate, heptanoate, octanoate, succinate, or
phenylacetate as the acyl substrate. Activity observed with ATP (representing 100%
activity) was nearly double that with GTP (57 ± 0.4%) and substantially higher than the
activities observed with ITP (15 ± 0.2%), CTP (4.1 ± 0.3%), or UTP (1.6 ± 0.2%); no
activity was observed with TTP or PPi.
Kinetic parameters
Kinetic parameters for EhACD were determined in both the acetate-forming and
acetyl-CoA forming directions (TABLE 2.1). Activity decreased above 6 mM ADP or 25
mM ATP in the respective directions of the reaction, so the concentrations of these
substrates were held below saturation in determination of kinetic parameters. Under
these conditions, acetyl-CoA and Pi in the acetate/ATP forming direction and acetate
and CoA in the acetyl-CoA forming direction followed Michaelis-Menten like kinetics. The
enzyme displayed similar Km values for acetyl-CoA and propionyl-CoA in the acetateforming direction of the reaction. However, the turnover rate kcat was approximately 5fold higher with acetyl-CoA versus propionyl-CoA, resulting in ~4-fold higher catalytic
efficiency with acetyl-CoA. The Km for Pi was similar with acetyl-CoA or propionyl-CoA as
the acyl substrate, but the Km for ADP was reduced ~2-fold with propionyl-CoA versus
acetyl-CoA. Similar Km and kcat values were observed with ADP and GDP (TABLE 2.1).
The Km values observed for EhACD are similar to those reported for the Giardia ACD
(0.02 mM, 0.23 mM, and 1.59 mM for acetyl-CoA, ADP, and Pi, respectively) (10).
As the enzyme assay used for determination of kinetic parameters in the acetateforming direction of the reaction measures CoA release in the first step, we confirmed
our results using a coupled enzyme assay that measures ATP production in the last step
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TABLE 2.1 Apparent kinetic parameters for EhACD in each direction of the
reaction.
Varied Substrate

kcat (sec-1)

Km (mM)

kcat/Km
(sec-1 mM-1)

Acetate-forming direction
Acetyl-CoA
Phosphate
ADP
GDP

0.04 ± 0.001
1.8 ± 0.18
1.6 ± 0.15
1.9 ± 0.14

110 ± 1.6
120 ± 7.8
140 ± 1.2
170 ± 5.2

2600 ± 370
65 ± 2.3
89 ± 7.9
90 ± 8.3

Propionyl-CoA
Phosphate
ADP

0.032 ± 0.002
1.5 ± 0.09
0.71 ± 0.09

21 ± 0.6
18 ± 0.6
24 ± 0.3

650 ± 63
12 ± 0.5
34 ± 3.4

240 ± 2.7
220 ± 4.3
320 ± 4.4
180 ± 1.6

16 ± 0.5
1100 ± 57
27 ± 0.7
18 ± 0.1

190 ± 1.5
260 ± 2.0
240 ± 7.1

6.3 ± 0.3
160 ± 4.3
33 ± 2.2

Acetyl-CoA forming direction
Acetate
14 ± 0.6
CoA
0.20 ± 0.01
ATP
12 ± 0.4
GTP
10 ± 0.1
Propionate
CoA
ATP

29 ± 1.4
1.6 ± 0.05
7.2 ± 0.7
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of the reaction. Similar Km and kcat values were observed with this assay (acetyl-CoA,
0.017 ± 0.001 mM, 130 ± 14 sec-1; KH2PO4, 2.1 ± 0.21 mM, 180 ± 16 sec-1; ADP, 0.94 ±
0.16 mM, 140 ± 7.2 sec-1).
In the acetyl-CoA forming direction of the reaction, the Km for acetate was ~2-fold
higher than that for propionate (TABLE 2.1); however, the kcat values were similar for
both substrates, unlike in the opposite direction. Thus, the catalytic efficiency of EhACD
with acetate was only 2.6-fold higher than with propionate. The Km for CoA was ~2-fold
elevated with propionate versus acetate as the acyl substrate, but the Km for ATP was
slightly reduced. The Km values for ATP and GTP were similar, but the turnover rate was
1.8-fold reduced with GTP. The overall catalytic efficiency with ATP was only 1.5-fold
higher than with GTP, indicating that both are suitable substrates. Although weak activity
was observed with butyrate, kinetic parameters could not be determined as the enzyme
was unsaturable for butyrate even at concentrations as high as 1 M.
Enzyme inhibition
Since ACD can function to produce either ATP or acetyl-CoA, regulation of this
enzyme may be important for maintaining proper levels of these metabolites in the cell.
An array of metabolic intermediates was tested as effectors for ACD (FIG 2.3). ATP and
PPi were found to be potent inhibitors in the acetate-forming direction of the reaction,
producing greater than 95% inhibition at 10 mM final concentration (FIG 2.3).
Additionally, 50% or less activity was observed in the presence of 10 mM glyoxylate (32
± 2%), NAD+ (47 ± 3%), or glucose-6-phosphate (50 ± 5%). In the acetyl-CoA forming
direction, only weak to moderate inhibition was observed with any of the compounds
tested (FIG 2.3). PPi had only a moderate effect in this direction, reducing activity to 64 ±
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FIG 2.3 Effect of various metabolites on EhACD activity. Activities were determined
in each direction of the reaction using Km concentrations of substrate in the presence or
absence of the indicated metabolites at a final concentration of 10 mM. Note that ATP
was tested only in the acetate-forming direction since it serves as a substrate in the
acetyl-CoA forming direction. Activities are normalized to the activity observed in the
absence of added metabolites. Black bars: activity in the acetate-forming direction. Gray
bars: activity in the acetyl-CoA forming direction. Activities are the mean ± SD of three
replicates. Abbreviations: cAMP, cyclic AMP; AcP, acetyl phosphate; G6P, glucose 6phosphate; F6P, fructose 6-phosphate; F16BP, fructose 1,6-bisphosphate.
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4% when present at 10 mM final concentration in the reaction. ATP is a substrate in this
direction, and although it does inhibit at higher concentrations, we did not examine this
further.
In addition to the intermediates shown in FIG 2.3, glyceraldehyde-3-phosphate,
phosphoenolpyruvate, and oxaloacetate were tested but only in the acetyl-CoA forming
direction because they interfere with the assays used for the acetate-forming direction.
None of these compounds resulted in any substantial inhibition in this direction, with 85 ±
0.3%, 85 ± 5.1%, and 90 ± 1.4% activity observed, respectively. IC50 values for ATP and
PPi in the acetate-forming direction were determined to be 0.81 ± 0.17 mM for ATP and
0.83 ± 0.27 mM for PPi. The estimated intracellular concentrations of ATP and PPi in E.
histolytica trophozoites grown in the presence of glucose are 5 ± 2 mM and 0.45 mM
(35), respectively, suggesting that regulation of the acetate-forming activity of ACD by
ATP and PPi is biologically relevant. The mode of inhibition by each of these compounds
was determined by kinetic analysis in which the concentration of inhibitor was varied
versus one substrate and the concentrations of the other two substrates were held
constant. These analyses suggest mixed inhibition by ATP (FIG 2.4) and PPi (FIG 2.5)
versus each substrate.
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FIG 2.4 The inhibitory effect of ATP versus ADP, acetyl-CoA, and phosphate in the
acetate-forming direction. Activity was determined in the presence of varying ATP
concentrations with concentration of one substrate varied and the others held constant.
ATP concentrations used were 0 mM ($), 0.2 mM (○), 0.35 mM (■), and 0.5 mM (□).
ATP inhibition patterns observed versus (A) ADP, (B) acetyl-CoA, and (C) KH2PO4.
Activities are the mean ± SD of three replicates.
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FIG 2.5 The inhibitory effect of PPi on ADP, acetyl-CoA, and phosphate in the
acetate-forming direction. Activity was determined in the presence of varying PPi
concentrations with concentration of one substrate varied and the others held constant.
PPi concentrations used were 0.6 mM ($), 2 mM (○), 3.5 mM (■), and 6 mM (□). PPi
inhibition patterns observed versus (A) ADP, (B) acetyl-CoA, and (C) KH2PO4. Activities
are the mean ± SD of three replicates.
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V.

DISCUSSION

Substrate specificity of EhACD and comparison to other characterized ACDs
Although ACD is not widespread, characterization of P. furiosus ACDs has
demonstrated that there are at least two different isoforms (11,12). This was confirmed
by characterization of additional enzymes from A. fulgidus (18) and T.kodakarensis (19).
The ACD I isoforms prefer acetate and acetyl-CoA and can typically utilize propionate,
butyrate, and propionyl-CoA as well, but do not tend to use longer or branched chain
acyl/acyl-CoA derivatives (11,12,16,18,20). The ACD II isoforms prefer longer acyl/acylCoA derivatives such as phenylacetyl-CoA/phenylacetate and indoleacetate as
substrates (12,18,19). Based on our characterization of recombinant EhACD and the
previous characterization of the partially purified native EhACD (7), this enzyme belongs
to the ACD I class. The Giardia enzyme also appears to belong to this class (10).
All ACDs utilize ADP but the ability to accept GDP as a substrate varies
(11,12,16). In contrast to SCS which has an isozyme specific for each (24), and the G.
lamblia ACD which functions only with ADP (10), EhACD is able to utilize ADP and GDP
interchangeably with similar Km and kcat values for each. However, EhACD may be more
likely to utilize ADP in vivo since the estimated intracellular concentration of ADP is
higher than that for GDP (3.3 ± 1.2 mM versus 0.7 mM, respectively (35)). Furthermore,
the intracellular concentration for ADP is above the Km value for ADP whereas that the
intracellular GDP concentration is below the Km value. Like EhACD, Entamoeba
phosphoglycerate kinase can use both ADP and GDP but shows a strong preference for
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GDP as judged by an order of magnitude difference between the Km values for these
substrates (4).
In the acetyl-CoA forming direction of the reaction, the enzyme does not show a
clear preference for ATP or GTP as the kinetic parameters with each substrate are
similar. The fact that the intracellular concentrations of ATP and GTP (5 ± 2 mM and 1.8
mM, respectively (35)) are both below the Km values for these substrates may suggest
that the acetate/ATP-forming direction of the reaction is favored in the cell, even though
the purified enzyme has similar activity in both directions. The higher catalytic efficiency
observed with either substrate in the acetate-forming direction versus the acetyl-CoA
forming direction is consistent with this.
A comparison of the characterized ACD I enzymes reveals a great deal of
variability. All of the characterized enzymes catalyze the acetate/ATP forming reaction,
but an acetyl-CoA forming activity was not detected or was very low for the ACDs from
G. lamblia (8-10), P. aerophilum (16), and M. jannaschii (18). A range of Km values has
been observed for each substrate in both directions of the reaction (TABLE 2.2). Within
the archaea, for which six ACD I enzymes have been characterized, the Km for a given
substrate in the acetyl-CoA forming direction showed up to an 11-fold range in values. In
the acetate/ATP forming direction, Km values ranged up to 41-fold for acetyl-CoA. The
Km values observed for the single characterized bacterial ACD from C. aurantiacus were
within the range of values observed with the archaeal enzymes. Likewise, the Km values
observed for the G. lamblia enzyme were within or near those for the archaeal enzymes.
For EhACD, the Km values for acetyl-CoA and Pi were comparable to those for
other enzymes, but the Km for ADP was substantially higher. In the acetyl-CoA forming
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TABLE 2.2 A comparison of Km values for characterized ACD I enzymes
Substrate
Acetyl-CoA
Phosphate
ADP
Acetate
CoA
ATP

Archaeal ACDs
Km (µM)
10a – 410b
100d – 1300b,c
7a – 150d

Bacterial ACDf
Km (µM)
37
1000
91

Giardia ACDg
Km (µM)
20
1590
230

EhACD
Km (µM)
40
1800
1600

340a – 1700b
5.6e – 60b
56e – 477d

900
24
570

NA
NA
NA

14000
200
12000

a

Archaeoglobus fulgidus (18)
Haloarcula marismortui (16)
c
Pyrobaculum aerophilum (16)
d
Pyrococcus furiosus (12)
e
Thermococcus kodakarensis (19)
f
Chloroflexus aurantiacus (20)
g
Giardia lamblia (10)
b

ND, no activity detected in the direction of acetyl-CoA formation.
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direction, the Km value for CoA was slightly above the range observed for other ACDs.
However, the Km for acetate was 8-fold higher than the highest Km observed for any
other ACD, and the Km for ATP was over 20-fold higher. This may suggest that acetylCoA formation is not the preferred direction of the reaction and that E. histolytica may
employ this direction only under specific environmental or physiological conditions (see
below).
Role of the extended glycolytic pathway
The PPi-dependent extended glycolytic pathway branches after production of
acetyl-CoA from pyruvate. In one branch, ACD is responsible for production of acetate
and ATP; in the other, acetyl-CoA is metabolized to ethanol by ADHE (6). Montalvo et al.
(36) and Reeves et al. (7) showed that ethanol and acetate are produced at
approximately a 2:1 ratio under anaerobic conditions versus a 1:2 ratio under aerobic
conditions. More recently, Pineda et al. (37) found an ethanol to acetate ratio of 3.9:1
produced in cells growing under standard conditions. Upon exposure to oxygen
saturated medium, however, the flux through acetate increased for up to 90 minutes.
The flux through ethanol decreased but gradually recovered over time. Overall, these
results suggest ethanol and acetate are both important end products of glycolysis, and
that flux through both of these pathways may be necessary to generate sufficient ATP
while still providing for NAD+ recycling.
ACD may also play a role in ATP production from amino acid catabolism
In addition to increasing ATP production from glycolysis, the presence of ACD
and PFOR allows certain amino acids to be catabolized for ATP production. E.
histolytica trophozoites scavenge a number of amino acids. Asparagine, aspartate, and
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tryptophan are broken down to pyruvate, and methionine, threonine, and homocysteine
are broken down to 2-oxobutanoate (38). PFOR converts these products respectively to
acetyl-CoA and propionyl-CoA (7,39,40), which can then serve as substrates of ACD for
ATP production.
Regulation of ACD activity
Although metabolic flux analysis using kinetic modeling suggested that ACD has
little regulatory effect over glycolysis (35), its roles in amino acid degradation were not
taken into account. Contrarily, one might expect that ACD’s position in the extended
glycolytic pathway of E. histolytica makes it a prime site for regulation in order to
properly maintain ATP and acetyl-CoA concentrations. In fact, we have found that
EhACD is regulated by both ATP and PPi in the acetate-forming direction with IC50
concentrations that are within the physiological range based on the estimated
intracellular concentrations for each (35). An excess of ATP would indicate that energy
needs of the cell are being met, and thus additional ATP production by ACD would be
unnecessary. This would prevent costly depletion of acetyl-CoA, which could instead be
used by other pathways.
PPi serves as a phosphoryl donor for two PPi-dependent glycolytic enzymes in E.
histolytica (4). A buildup of PPi may signal a backup in glycolysis that would again
warrant inhibition of ACD to prevent depletion of acetyl-CoA. Finally, regulation of ACD
by two components of the glycolytic pathway may provide a means for shunting acetylCoA to ADHE for ethanol production to regenerate NAD+, thus maintaining a proper
balance between these two alternative pathways.

78

Differences between G. lamblia and E. histolytica allow these microorganisms to
occupy diverse habitats
Although E. histolytica and G. lamblia rely on similar extended PPi-dependent
glycolytic pathways, the E. histolytica ACD is able to function in both the acetate-forming
and acetyl-CoA forming directions of the reaction, whereas the Giardia enzyme is limited
to just the acetate-forming direction (10). This divergence may have arisen due to the
different environments these parasites inhabit during infection. Entamoeba trophozoites
reside in the mucus layer of the colon where bacterial microflora produce high amounts
of the small chain fatty acids (SCFA) acetate, propionate, and butyrate (41). Giardia
colonizes the small intestine in which the SCFA concentration is relatively low (41), and
thus it is unlikely that ACD will be needed to function in acetate utilization.
The total SCFA concentration in the human colon is approximately 100-120 mM,
with relative molar ratios of 57:22:21 acetate:propionate:butyrate (41), giving
approximate concentrations of 57-68 mM for acetate, 22-26 mM for propionate, and 2125 mM for butyrate. Acetate and propionate concentrations are thus in a range that
would suggest ACD’s activity in the acetyl-CoA forming direction may be physiologically
relevant and that ACD may switch from acetate/ATP production when glucose is present
to SCFA utilization when glucose becomes limiting.
Concluding remarks
Although we have speculated on the roles of ACD in Entamoeba, experimental
confirmation still remains. In addition to Entamoeba and Giardia, ACD may also be
present in other parasites including Cryptosporidium muris, Blastocystis hominis, and
Plasmodium falciparum. The possible existence of ACD in Plasmodium is of particular
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interest, not only because of its enormous public health significance, but also because
they retain fully functional mitochondria. Within the complex life cycle of Plasmodium, the
intraerythrocyte stages rely primarily on the incomplete oxidation of blood glucose by
glycolysis to produce ATP (42,43), and thus ACD may play a similar role as in
Entamoeba. Whether ACD plays similar roles in other parasites must still be
investigated, and may provide insight into energy metabolism in these important
eukaryotic pathogens.
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CHAPTER 3

INVESTIGATING THE MECHANISM OF ADP-FORMING ACETYL-COA SYNTHETASE
FROM THE PROTOZOAN PARASITE ENTAMOEBA HISTOLYTICA

Cheryl P. Jones, Kirin Khan, and Cheryl Ingram-Smith

I.

ABSTRACT

ADP-forming acetyl-CoA synthetase catalyzes the reversible conversion of
acetyl-CoA to acetate to generate ATP via substrate level phosphorylation or to activate
acetate to acetyl-CoA. Investigation of the Pyrococcus furiosus ACD suggested a novel
four-step mechanism involving two phosphohistidine intermediates. The Pyrococcus
enzyme is an α2β2 heterotetramer with one phosphorylated His in each subunit. In this
study, the enzymatic mechanism of E. histolytica ACD was investigated through kinetic
characterization of site-altered variants. The homodimeric E. histolytica enzyme has α
and β domains fused into a single subunit. Our results indicate that of the two proposed
phosphorylation sites, only His252 (equivalent to Hisα of P. furiosus ACD) is essential
but His533 (equivalent to Hisβ) is important for activity but not essential. Glu213,
proposed to be involved in phosphorylation of Hisα, was also shown to be essential and
replacements at this position resulted in complete loss of activity. Asp674, thought to
play a role in stabilization of the phosphorylated His, plays an important role in catalysis
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as replacement with Ala resulted in substantial loss of activity that was partially
recovered by more conservative replacement with Glu. Our kinetic data, isotopic labeling
and distance calculations within the active site of the recently solved structure of
Candidatus Korarchaeum cryptofilum ACDI challenge the proposed four-step
mechanism and suggest that there is a single essential phosphorylated His, at least for
ACD enzymes with fused α and β domains.
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II.

INTRODUCTION

ADP-forming acetyl-CoA synthetase (ACD; E.C 6.2.1.13), belonging to the NDPforming acyl-CoA synthetase enzyme superfamily (1), is an acetate thiokinase capable
of substrate-level phosphorylation (Eq. 1). Previously characterized ACD enzymes vary
in their substrate preference and ability to catalyze the reverse reaction (2-5), leading to
the designation of ACD I and II subtypes based on substrate utilization (6).
acetyl-CoA + NDP + Pi ⇌ acetate + CoA + ATP

[Eq. 1]

ACD has been identified in a number of acetate-producing prokaryotes, including
multiple archaeal species (2,7,8) and the bacterium Chloroflexus aurantiacus (4), that
lack the traditional acetate kinase/phosphotransacetylase pathway for acetate
production. ACD is also present in the parasitic protozoan species Entamoeba histolytica
(9) and Giardia lamblia (10) which are both anaerobic intestinal parasites that lack
mitochondria. In E. histolytica, ACD may function in energy conservation by providing
ATP via substrate level phosphorylation (11) and CoA recycling (12), but may also
function in the reverse direction for acetate utilization (11). Putative ACD sequences
have also been identified in other parasitic protozoan species such as Plasmodium
falciparum and Cryptosporidium muris (11).
Succinyl-CoA synthetase (SCS; EC 6.2.1.4), the most well-studied member of
the enzyme superfamily to which ACD belongs, consists of five domains arranged in two
subunits designated as alpha and beta. These five subunits are present in ACD but are
arranged differently within the primary sequence (FIG 3.1A). SCS is a heterotetrameric
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FIG 3.1 Comparison of ACD and SCS. (A) Diagram of the domain organization in ACD
and SCS. Each is comprised of five domains arranged in a unique pattern. The optional
hinge region present in some ACD enzymes is represented by the black rectangle. (B)
Sequence alignment of E. coli SCS and ACD from multiple organisms. α and β indicate
the respective subunit for those enzymes in which the alpha and beta domains are
separate subunits.
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enzyme with two active sites, one residing in each alpha-beta dimer (13). Most
prokaryotic ACDs exist as a heterotetramer of two alpha and two beta subunits, as for
SCS (1). The only known exception with more than two α-β units is ACD from C.
aurantiacus, which is a homotetramer (4). Eukaryotic G. lamblia and E. histolytica ACDs
(3,11), along with Archaeal Archaeoglobus fulgidus and Methanococcus janaschii ACDs
(14), are encoded by a single gene and have fused alpha and beta domains connected
by a novel hinge region. This represents a unique adaptation that adds complexity to this
class of enzymes.
Structural analyses of SCS from E. coli (15), pig heart (16) and Thermus
aquaticus (17,18) have revealed the active site and substrate binding sites. The threestep mechanism of SCS proceeds through a single phosphorylated enzyme
intermediate.
Step 1:

succinyl-CoA + Pi + E ⇌ E~succinyl-P + CoA

Step 2:

E~succinyl-P ⇌ E-Hisα-P + succinate

Step 3:

E-Hisα-P + ADP ⇌ E + ATP

The succinyl-CoA and phosphate binding pockets are located in the alpha subunit of
SCS in a region designated as Site I. After binding succinyl-CoA, a succinyl-phosphate
intermediate is formed and CoA is released (Step 1). The phosphoryl group is then
transferred to a His residue (Hisα) located within a loop in the alpha subunit (designated
as the phosphohistidine loop) and succinate is released (Step 2). It was postulated that a
conformational change subsequently swings this phosphohistidine loop from its Site I
position to a position closer to the nucleotide binding site of the beta subunit (Site II)
(15). The phosphoryl group is then transferred to a nucleotide diphosphate and the
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newly formed nucleotide triphosphate is released (Step 3). Two additional glutamate
residues of E. coli SCS have been investigated and determined to be crucial for the
phosphorylation and dephosphorylation of the active site histidine (19).
The mechanism of ACD was originally thought to be analogous to that of SCS;
however, Brasen et al. (20) observed phosphorylation of both alpha and beta subunits of
P. furiosus ACD (PfACD) when incubated with 32P-labeled ATP or Pi. They proposed a
four-step mechanism containing an additional phosphoryl transfer step (Step 3) to a
separate His residue located in the beta subunit (Hisβ).
Step 1:

acetyl-CoA + Pi + E ⇌ E~acetyl-P + CoA

Step 2:

E~acetyl-P ⇌ E-Hisα-P + acetate

Step 3:

E-Hisα-P ⇌ E-Hisβ-P

Step 4:

E-Hisβ-P + ADP ⇌ E + ATP

Recently, the first structural characterization of an ACD from the
hyperthermophilic archaea Candidatus Korachaeum cryptofilum (ckcACD) was
performed (21). This enzyme was crystallized with different ligands to reveal nine
structures that include multiple structures showing the phosphorylated Hisα
intermediate. This study confirmed the postulated swinging mechanism of the
phosphohistidine loop from Site I to Site II of the active site.
In this study, we investigate the role of four primary residues within E. histolytica
ACD (EhACD) and assess their roles through kinetic characterization of site-altered
enzyme variants and isotopic labeling to examine phosphorylation. Our results contradict
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the proposed four-step mechanism for PfACD and instead agree with the original threestep mechanism proposed for SCS (15).
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III.

MATERIALS AND METHODS

Materials
Chemicals were purchased from Sigma-Aldrich, VWR International, Gold
Biotechnology, Fisher Scientific, Life Technologies, and J R Scientific. Primers were
purchased from Integrated DNA Technologies
Sequence alignment
Putative ACD amino acid sequences were identified by PSI-BLAST
(http://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins) (22) using the E. histolytica ACD
sequence as the query (GI: 67481881). Sequences were aligned using ClustalW
(http://www.ebi.ac.uk/Tools/msa/clustalo/) (23).
Site-directed mutagenesis of acd
Site-directed mutagenesis of an Escherichia coli codon-optimized E. histolytica
acd gene was performed using the Quikchange Lightning Kit (Stratagene, Inc.)
according to manufacturer’s specifications. Primers used are listed in TABLE 3.1.
Alterations were confirmed by sequencing by Clemson University Genomics Institute
(CUGI).
Heterologous production of enzyme variants
Plasmids were transformed into E. coli Rosetta2(DE3)pLysS cells (Novagen).
ACD and its variants were purified as in (11). Briefly, cells with the altered or unaltered
pET21b-ACD constructs were grown in LB medium and protein production was induced
by the addition of IPTG. Cells were resuspended in ice-cold buffer A (25 mM Tris-HCl,
500 mM NaCl, 10% glycerol, 25 mM imidazole [pH 7.3]) and disrupted. Cell-free extract
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TABLE 3.1 Primers used for site-directed mutagenesis.
Variant
His252Ala
His533Ala
His533Asp
His533Glu
His533Lys
His533Asn
His533Gln
His533Arg
Asp674Ala
Asp674Glu
Asp674Asn
Glu213Ala
Glu213Asp
Glu213Gln

Dir
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R

Primer Sequence
5’ GCAGCGGCCATGAGTGCTACCGGTAGCCTGGCC 3’
5’ GGCCAGGCTACCGGTAGCACTCATGGCCGCTGC 3’
5’ GAGTCCGGATATTATGGCTAAAACCGATGTTGG 3’
5’ CCAACATCGGTTTTAGCCATAATATCCGGACTC 3’
5’ GAGTCCGGATATTATGGATAAAACCGATGTTGGCGG 3’
5’ CCGCCAACATCGGTTTTATCCATAATATCCGGACTC 3’
5’ GAGTCCGGATATTATGGCGAAAACCGATGTTGGCGG 3’
5’ CCGCCAACATCGGTTTTCTCCATAATATCCGGACTC 3’
5’ GAGTCCGGATATTATGAAGAAAACCGATGTTGGCGG 3’
5’ CCGCCAACATCGGTTTTCTTCATAATATCCGGACTC 3’
5’ GAGTCCGGATATTATGAACAAAACCGATGTTGGCGG 3’
5’ CCGCCAACATCGGTTTTGTTCATAATATCCGGACTC 3’
5’ GAGTCCGGATATTATGCAGAAAACCGATGTTGGCGG 3’
5’ CCGCCAACATCGGTTTTCTGCATAATATCCGGACTC 3’
5’ GAGTCCGGATATTATGCGTAAAACCGATGTTGGCGG 3’
5’ CCGCCAACATCGGTTTTACGCATAATATCCGGACTC 3’
5’ CCCGGAAATCTCTGAAGTTGCTATTAATCCGCTGGCCGTG 3’
5’ CACGGCCAGCGGATTAATAGCAACTTCAGAGATTTCCGGG 3’
5’ GAAATCTCTGAAGTTGAAATTAATCCGCTGGCC 3’
5’ CCGCCAACATCGGTTTTACGCATAATATCCGGACTC 3’
5’ GAAATCTCTGAAGTTAATATTAATCCGCTGGCC 3’
5’ GGCCAGCGGATTAATATTAACTTCAGAGATTTC 3’
5’ GTCTATCCTGATGTACATCGCAAGTATCAAAGATGCCAAA 3’
5’ TTTGGCATCTTTGATACTTGCGATGTACATCAGGATAGAC 3’
5’ TCCTGATGTACATCGACAGTATCAAAGATGCC 3’
5’ GGCATCTTTGATACTGTCGATGTACATCAGGA 3’
5’ TCCTGATGTACATCCAAAGTATCAAAGATGCC 3’
5’ GGCATCTTTGATACTTTGGATGTACATCAGGA 3’
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was applied to a 5 ml HisTrap HP nickel affinity column (GE Healthcare) equilibrated
with buffer A and protein was eluted using a linear gradient from 0.025-0.5M imidazole.
Fractions containing enzyme were pooled, dialyzed overnight in 25 mM Tris-HCl, 10%
glycerol [pH 7.3], aliquoted, and stored at -80°C. Enzyme was verified to be
electrophoretically pure by SDS-PAGE analysis . Protein concentration was determined
spectrophotometrically using the Take3 Micro-volume plate (BioTek).
Determination of kinetic parameters
Enzymatic activity in the acetate-forming direction was determined by measuring
release of CoASH from acyl-CoA using Ellman’s thiol reagent (5,5'-dithio-bis-[2nitrobenzoic acid], DTNB) (24). Production of NTB2- by CoASH cleavage of DTNB was
measured spectrophotometrically at 412 nm. Assays were performed in 96-well plates in
0.2 ml reaction volumes. Reaction mixtures contained 50 mM Tris-HCl, 0.3 mM DTNB,
and 6 mM HEPES (used to solubilize DTNB) [pH 7.3]) with varied substrate
concentrations. Reactions were pre-incubated at 37°C for 5.5 minutes and initiated by
the addition of enzyme. Absorbance was measured every 4 seconds at 37°C using a
Synergy HT Multi-Mode Microplate Reader (BioTek). Initial velocities were converted to
µmol CoASH formed using an extinction coefficient of ε = 13.6 mM-1 cm-1 for the
thiophenolate NTB2- anion. One unit of activity is defined as 1 μmol product per minute
per mg protein.
Enzymatic activity in the acetyl-CoA forming direction was determined using the
hydroxamate assay (25,26). Reaction mixtures contained 50 mM Tris-HCl [pH 7.3] and
300 mM hydroxylamine-HCl [pH 7.0] with varied substrate concentrations in a volume of
0.15 ml. Reactions were pre-incubated at 37°C for 5.5 minutes, initiated by the addition
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of enzyme and incubated at 37°C, and terminated after a specified amount of time by the
addition of one volume of stop solution (2.5% FeCl3/2 N HCl/10% trichloroacetic acid).
Product formation was determined by absorbance at 540 nm and comparison to a
standard curve. One unit of activity is defined as 1 µmol of acetyl-CoA produced per
minute per mg protein. Saturating substrate concentrations for each variant are
summarized in TABLE 3.2.
Apparent kinetic parameters were determined by varying the concentration of a
single substrate while the other substrates were held at constant saturating
concentrations. For determination of the apparent steady-state kinetic parameters Km
and kcat and their standard deviations, nonlinear regression in KaleidaGraph (Synergy
Software) was used to fit the data to the Michaelis-Menten equation.
Radiolabeled phosphorylation assay
In order to detect phosphorylated enzyme intermediates, 17 µg enzyme was
incubated for 15 minutes at 37°C with either 2.5 µCi of [γ-32P]ATP (10 mM) or 1 µCi 32Pi
(4 mM) and 0.3 mM acetyl-CoA. Mixtures also contained 50 mM Tris-HCl [pH 8.0]. An
equal volume of 2X SDS buffer (5% β-mercaptoethanol, 2% SDS, 25% glycerol, 0.625 M
Tris-HCl pH6.8, 0.01% bromophenol blue) was added to the solution and 15 µl was
subjected to SDS-PAGE. The gel was dried overnight and autoradiographed. Image
quantification was performed using ImageJ. Statistical analysis was performed using
paired one-tail t-tests.
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Distance Calculations
The ckcACDI-c structure (4XZ3) was obtained from the PDB database. Distance
was measured between two atoms using the ‘monitor distance’ function in Accelrys
Discovery Studio 3.5.
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TABLE 3.2 Optimized assay conditions for wild type and variant enzymes.
Acetyl-CoA forming direction
Time
mM
mM
mM
(min) acetate CoA MgATP

Enzyme
WT

1.1

15

100

1

20

0.019

300

8

5

His

533

Arg

13.4

15

75

0.4

12.5

0.36

300

8

3

His

533

Lys

7.4

25

100

0.8

15

0.74

300

8

5

Ala

8.2

10

4

0.6

12.5

0.82

200

8

3

Asn

9.1

45

50

0.2

20

1.52

300

8

5

Gln

10.2

45

30

0.3

15

1.13

300

10

4

Asp

27.8

45

75

0.4

12.5

11.1

300

8

5

24.8

50

5

0.8

15

9.9

300

6

3

Ala

21

10

6

1

20

0.82

300

10

3

Asn

17.9

30

5

0.2

20

1.5

300

8

6

0.91

20

200

0.7

25

0.09

300

8

5

His
His

533

His
His

533

533

533

His

533

Asp
Asp

Glu

674

674

Asp

674

Glu
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µg
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Acetate-forming direction
µM
mM
mM
AcCoA
Pi
MgADP

µg
enz

IV.

RESULTS

His252 (Hisα) and His533 (Hisβ), the two His residues proposed to be directly
phosphorylated during the ACD reaction (20), are conserved among ACDs but only Hisα
is conserved across the NDP-forming acyl-CoA synthetase superfamily (FIG 3.1B).
These residues were individually changed to alanine and the variants were assayed for
activity in each direction of the reaction. Similar to what was observed with P. furiosus
ACD (20), the His252Ala variant was not active in either direction confirming this residue
is essential for activity (FIG 3.2A). Surprisingly, the His533Ala variant retained weak
activity in both directions.
To investigate this further, additional variants were created in which His533 was
altered to the positively charged residues Arg and Lys, the neutral Asn and Gln, and
negatively charged Asp and Glu. Although each of the His533 variants had less than
25% activity compared to wild-type, activity corresponded to the charge of the
replacement residue (FIG 3.2A). Substitution of His with a positively charged residue
resulted in higher activity than replacement with an uncharged residue. Replacement
with a negatively charged residue was the most deleterious (FIG 3.2A).
Apparent kinetic parameters were determined for the His533 variants in both
directions of the reaction. In the acetate-forming direction (TABLE 3.3), Km values for
acetyl-CoA and ADP were slightly decreased for the variants versus the wild type. The
Km values for Pi were more variable, ranging from a 10- to 12-fold decrease observed
with the His533Glu and His533Arg variants to a 1.8-fold increase with the His533Lys

99

FIG 3.2 Percent activity of EhACD variants. Activity was determined in the acetyl-CoA
forming direction (solid red) and in the acetate-forming direction (blue diagonal pattern).
Activities are represented as a percentage of the activity observed for the wild type
enzyme (100%). Activity was normalized to wild-type. (A) Activity of the His252 and
His533 variants. (B) Activity of the Glu213 and Asp674 variants.
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TABLE 3.3 Apparent kinetic parameters of the His533 variants in the acetateforming direction.

Acetate-forming direction
Acetyl-CoA WT#
His533Arg
His533Lys
His533Ala
His533Asn
His533Gln
His533Asp
His533Glu
ADP
WT#
His533Arg
His533Lys
His533Ala
His533Asn
His533Gln
His533Asp
His533Glu
Pi
WT#
His533Arg
His533Lys
His533Ala
His533Asn
His533Gln
His533Asp
His533Glu
#

Fold
Change

Km (mM)
0.043 ± 0.005
0.016 ± 0.003
0.030 ± 0.003
0.010 ± 0.001
0.015 ± 0.0003
0.019 ± 0.004
0.027 ± 0.008
0.012 ± 0002
1.56 ± 0.15
0.64 ± 0.18
0.97 ± 0.14
0.41 ± 0.03
0.57 ± 0.15
1.28 ± 0.08
0.60 ± 0.08
1.19 ± 0.08
1.77 ± 0.18
0.15 ± 0.03
3.25 ± 0.35
0.75 ± 0.10
0.94 ± 0.25
0.86 ± 0.21
0.25 ± 0.08
0.18 ± 0.04

as reported in (11)
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-2.7x
-1.4x
-4.3x
-2.9x
-2.3x
-1.6x
-3.6x
-2.4x
-0.6x
-3.8x
-2.7x
-1.2x
-2.6x
-1.3x
-11.8x
+1.8x
-2.4x
-1.9x
-2x
-7x
-9.8x

kcat (sec-1)
111 ± 2
17.6 ± 1.4
2.35 ± 0.21
2.68 ± 0.09
1.39 ± 0.06
1.73 ± 0.13
1.62 ± 0.17
0.12 ± 0.001
138 ± 1
19.6 ± 1.8
3.27 ± 0.46
2.80 ± 0.14
1.37 ± 0.08
2.48 ± 0.10
1.71 ± 0.09
0.27 ± 0.03
115 ± 8
13.9 ± 1.0
3.12 ± 0.37
2.26 ± 0.09
1.49 ± 0.11
1.76 ± 0.12
1.66 ± 0.14
0.22 ± 0.01

Fold
Change
-6.3x
-47x
-41x
-80x
-64x
-69x
-925x
-7x
-42x
-49x
-101x
-56x
-81x
-511x
-8.3x
-37x
-51x
-77x
-63x
-69x
-523x

variant when compared to wild-type (TABLE 3.3). However, kcat values displayed
significant decreases for all of the variants. The most severe decrease in kcat value was
observed for the His533Glu variant, and the least severe decrease was observed with
the His533Arg variant (TABLE 3.3).
In the acetyl-CoA forming direction of the reaction (TABLE 3.4), Km values for
CoA were only mildly affected with the exception of the His533Gln and His533Asp
variants, both of which displayed an 18-fold reduction for CoA. Likewise, the Km values
for ATP were not substantially affected, except for the His533Asp variant for which the
Km was decreased 10-fold.Km values for acetate showed the greatest effect for all
variants, ranging from an 8- to 45-fold decrease compared to wild-type (TABLE 3.4). The
kcat values for all of the His533 variants were greatly reduced, ranging from ~40-fold
decreased (His533Arg) to over 1300-fold decreased (His533Asp). Replacement of His
533 with a positively charged residue had the least deleterious effect whereas
replacement with a negatively charged residue had the most severe effect (TABLE 3.4).
Glu212α and Glu197β were originally identified in E. coli SCS for their role in
phosphorylation and dephosphorylation of the catalytic Hisα residue (16). Therefore, we
wanted to investigate the potential roles of the homologous residues in EhACD, Glu213
and Asp674. Substitution of Glu213 with Ala, Asn, or Asp resulted in little to no activity
(FIG 3.2B), suggesting that this residue is essential.
Asp674 is analogous to E. coli SCS Glu197β and P. furiosus ACDI Asp212β
(FIG 3.1). Substitution of Asp674 with Ala or Asn markedly reduced activity that was
partially rescued when replaced with Glu (FIG 3.2B), consistent with corresponding
changes in P. furiosus ACD (20) and E. coli SCS (19). Apparent kinetic parameters for
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TABLE 3.4 Apparent kinetic parameters of the His533 variants in the acetyl-CoA
forming direction.

Acetyl-CoA forming
direction
Acetate WT#
His533Arg
His533Lys
His533Ala
His533Asn
His533Gln
His533Asp
His533Glu
CoA
WT#
His533Arg
His533Lys
His533Ala
His533Asn
His533Gln
His533Asp
His533Glu
ATP
WT#
His533Arg
His533Lys
His533Ala
His533Asn
His533Gln
His533Asp
His533Glu
#

Km (mM)
14 ± 0.61
1.7 ± 0.8
0.84 ± 0.60
0.68 ± 0.10
0.76 ± 0.70
0.55 ± 0.20
0.31 ± 0.02
0.40 ± 0.01
0.20 ± 0.01
0.10 ± 0.004
0.13 ± 0.01
0.07 ± 0.01
0.08 ± 0.004
0.011 ± 0.001
0.011 ± 0.001
0.26 ± 0.02
12 ± 0.40
2.5 ± 0.16
1.7 ± 0.10
2.2 ± 0.10
7.7 ± 0.6
2.5 ± 0.13
1.2 ± 0.20
3.9 ± 0.10

Fold
Change
-8x
-17x
-21x
-18x
-25x
-45x
-35x
-2x
-1.5x
-3x
-2.5x
-18x
-18x
+1.3x
-5x
-7x
-5x
-1.6x
-5x
-10x
-3x

as reported in (11)
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kcat (sec-1)
233 ± 2.7
5.6 ± 0.09
3.4 ± 0.04
3.3 ± 0.09
1.5 ± 0.02
1.2 ± 0.02
0.18 ± 0.01
0.26 ± 0.002
328 ± 5.3
7.0 ± 0.15
4.1 ± 0.04
4.2 ± 0.08
2.0 ± 0.1
1.3 ± 0.03
0.25 ± 0.01
0.27 ± 0.003
320 ± 4.4
6.6 ± 0.06
3.7 ± 0.09
3.3 ± 0.03
2.0 ± 0.10
1.4 ± 0.03
0.25 ± 0.01
0.28 ± 0.002

Fold
Change
-42x
-69x
-71x
-160x
-194x
-1294x
-896x
-47x
-80x
-78x
-161x
-252x
-1312x
-1215x
-48x
-86x
-97x
-160x
-230x
-1280x
-1140x

the Asp674 variants revealed only weak changes in Km for any substrate in either
direction of the reaction with the exception of acetate, for which Km values decreased
over 10-fold for the Asp674Ala and Asp674Glu variants (TABLE 3.5). The Asp674Glu
variant showed very modest reductions in kcat as compared to the Asp674Ala and
Asp674Asn variants, suggesting that the negative charge is important at this position
(TABLE 3.5).
Our kinetic results suggest that His252 and Glu213 residues are essential
residues; however, His533 and Asp674 are important for catalysis but not critical. Thus,
we wanted to analyze the influence of these residues on phosphorylation of the enzyme
during catalysis. Phosphorylation was assessed using isotopic labeling with either [γ32

P]ATP or 32Pi + acetyl-CoA and analyzed using autoradiography. Phosphorylation of

wild type EhACD was observed under both conditions (FIG 3.3). The His252Ala variant
was not phosphorylated by [γ-32P]ATP or 32Pi + acetyl-CoA (FIG 3.3A), consistent with
the lack of activity of this variant. In contrast, the His533Ala variant was phosphorylated
from both directions. Quantitative analysis indicated that this variant was
phosphorylated at levels similar to the wild type enzyme by 32Pi + acetyl-CoA, and ~20%
less by [γ-32P]ATP (FIG 3.3C). Phosphorylation was abolished in His252Ala, confirming
that this residue is essential for formation of the phosphorylated enzyme intermediate
(FIG 3.3A). A time course of phosphorylation for the wild-type and the His533Ala
enzymes showed no discernible difference in labeling between 15 seconds and 15
minutes, as judged by autoradiography (data not shown).
Phosphorylation of the Asp674Ala variant was observed by both 32Pi + acetylCoA and [γ-32P]ATP (FIG 3.3B). Labeling by 32Pi + acetyl-CoA was reduced to 62 ± 3.5%
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and to 47 ± 5.3% versus the wild type enzyme using [γ-32P]ATP (FIG 3.3D). In contrast,
the Glu213Ala variant was phosphorylated by [γ-32P]ATP but not by 32Pi + acetyl-CoA
(FIG 3.3B). Labeling by [γ-32P]ATP was similar to that for the wild type enzyme, whereas
labeling by 32Pi was absent (FIG 3.3D). This is consistent with the lack of enzymatic
activity for the Glu213 variants.
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FIG 3.3 Isotopic labeling of EhACD to detect phosphorylation. Enzymes were
labeled with 32P in the presence of acetyl-CoA + Pi (top panels) or ATP (bottom panels).
(A) Analysis of the His252Ala and His533Ala variants versus wild type. (B) Analysis of
the Glu213Ala and Asp674Ala variants.
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TABLE 3.5 Apparent kinetic parameters of the Asp674 variants in both directions
of the reaction.

Acetyl-CoA forming direction
Acetate
WT#
Asp674Ala
Asp674Asn
Asp674Glu
CoA

ATP

14 ± 0.61
1.3 ± 0.10
0.96 ± 0.05
3.9 ± 0.25

WT#
Asp674Ala
Asp674Asn
Asp674Glu
WT#
Asp674Ala
Asp674Asn
Asp674Glu

Pi

#

Fold
Change

kcat (sec-1)

Fold
Change

-11x
-15x
-3.6x

233 ± 2.7
2.9 ± 0.1
1.3 ± 0.1
50.3 ± 1.8

-80x
-179x
-4.6x

0.20 ± 0.01
0.12 ± 0.01
0.041 ± 0.004
0.24 ± 0.02

-1.7x
-5x
+1.2x

328 ± 5.3
4.2 ± 0.1
1.2 ± 0.1
44.3 ± 0.1

-78x
-273x
-7.4x

12 ± 0.4
4.0 ± 0.4
2.8 ± 0.2
4.6 ± 0.2

-3x
-4x
-2.6x

320 ± 4.4
3.2 ± 0.03
1.2 ± 0.02
53.0 ± 1.2

-99x
-267x
-6x

0.043 ± 0.005
0.012 ± 0.002
0.016 ± 0.002
0.022 ± 0.002

-3.6x
-2.7x
-2x

111 ± 2
2.45 ± 0.18
1.26 ± 0.11
15.8 ± 0.61

-45x
-88x
-7x

WT#
Asp674Ala
Asp674Asn
Asp674Glu

1.56 ± 0.15
1.42 ± 0.11
0.43 ± 0.01
1.44 ± 0.08

-1.1x
-3.6x
-1.1x

138 ± 1
2.86 ± 0.15
1.20 ± 0.11
25.0 ± 2.4

-48x
-115x
-5.5x

WT#
Asp674Ala
Asp674Asn
Asp674Glu

1.77 ± 0.18
0.39 ± 0.03
0.57 ± 0.05
2.84 ± 0.88

-4.5x
-3.1x
+1.6x

115 ± 8
2.64 ± 0.17
0.93 ± 0.04
24.5 ± 5.0

-44x
-124x
-4.7x

Acetate-forming direction
Acetyl-CoA WT#
Asp674Ala
Asp674Asn
Asp674Glu
ADP

Km (mM)

as reported in (11)
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V.

DISCUSSION

The catalytic Hisα is a defining feature of ACD enzymes
NDP-forming acyl-CoA synthetases participate in phosphoryl transfer through a
catalytic His residue. This phosphorylation was first observed in the structure of E. coli
SCS (27) and mutagenesis of this phosphorylated His residue in multiple forms of ATP
citrate lyase abolished enzymatic activity (28,29). Likewise, alteration of this His residue
in EhACD (His252) renders the enzyme completely inactive and incapable of
phosphorylation.
This catalytic Hisα residue is a defining feature of ACD enzymes and can be
useful in classifying putative enzymes from other organisms. This is especially important
in distinguishing between ACD and acetyltransferases such as PatZ from E. coli. These
acetyltransferases share homology with ACD (1) and have the same arrangement of
domains as ACD even though domain shuffling is uniquely common within this
superfamily of enzymes (1). However, acetyltransferases lack the critical catalytic Hisα
residue enabling them to be easily distinguished from acyl-CoA synthetases.
Role of Glu213 in phosphorylation of Hisα
E. coli SCS has two critical glutamate residues that play a role in phosphorylation
of the catalytic Hisα (16). Glu208α of SCS is conserved in ACDs and was shown to
interact directly with Hisα by accepting a hydrogen bond with N1 of the imidazole ring in
order to leave N3 unprotonated and thus stabilize the phosphohistidine (16). This
interaction was again confirmed with ckcACDI (21). Alteration of the homologous EhACD
residue Glu213 to Ala resulted in complete loss of activity. Even conservative
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replacement with Asp still resulted in barely detectible activity, which is consistent with
the highly reduced activity of Glu218Asp from P. furiosus ACD (20). It appears that ACD
has very little flexibility at this position. Isotopic labeling of the Glu213Ala variant are
intriguing because phosphorylation is eliminated when the enzyme is incubated with
acetyl-CoA and 32Pi, but not when incubated with [γ-32P]ATP, showing Glu213 is
essential for phosphorylation of Hisα in Site I but not for phosphorylation by ATP. This
suggests that phosphorylated Hisα is stuck in its Site II position and is unable to “swing”
back into the Site I position when Glu213 is absent. Alternatively, the Glu213Ala enzyme
may be phosphorylated on a residue other than Hisα and this would be unaffected by
Glu213.
Role of Asp674 in stabilization of phosphorylated Hisα
Glu197β in E. coli SCS was proposed to participate in stabilization of the
phosphorylated Hisα when positioned at Site II (19). The equivalent residue in EhACD is
Asp674 located in the ATP grasp domain. Alteration of this residue to Ala or Asn
resulted in a drastic loss of activity; however, replacement by Glu maintained partial
activity. This suggests that the carboxyl group of this Asp residue is important for
catalysis, which is consistent with the previously observed function of this residue. In the
ckcACDI structure, the equivalent Asp209β hydrogen bonds with the side chain of
Thr255α and the backbone nitrogen of His254α when the phosphohistidine segment is
pointing toward Site II (21). Consistent with this, the lack of a functional side chain in the
Asp674Ala variant reduced but did not eliminate the ability of ACD to be phosphorylated
in both directions of the reaction. Thr255α is conserved within all ACDs but is replaced
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by Ala in SCS (FIG 3.1B). Thus, if this Asp in ACD functions similarly to the equivalent
Glu in SCS, the hydrogen bonding pattern must differ.
The necessity of Hisβ phosphorylation remains undetermined
The reduced activity of the His533 variants undoubtedly establishes that this
residue is important for optimal catalysis in EhACD. However, the exact role it plays in
the catalytic mechanism remains unclear. Replacement of His68β in ckcACDI reduced
activity to ~ 1% that of the wild type enzyme when changed to Asn and 0.3% activity
when changed to Ala (21). These results are consistent with the effects of alterations at
His533 of EhACD, which resulted in highly reduced activity with the exception of
His533Arg. Multiple sequence alignment of members of the NDP-forming acyl-CoA
synthetase family demonstrated that this position is either occupied by a His as in ACD,
or by an Arg residue as in SCS, ACL, and MCS (1). Therefore, it was not entirely
surprising that the His533 variant with the highest activity was His533Arg. The partial
recovery of activity of the His533Arg variant versus the other variants suggests that
these two residues may have overlapping functions. The four-step mechanism in which
Hisβ is directly phosphorylated would oppose that possibility, since Arg would not
typically be capable of phosphorylation. Alternatively, if ACD-Hisβ is directly
phosphorylated, this step may potentially be bypassed when that His is replaced.
Isotopic labeling by [γ-32P]ATP and by 32Pi and acetyl-CoA suggests the
His533Ala variant is phosphorylated in both directions of the reaction, just as for the
wild-type enzyme. This result is inconsistent with the proposed four-step mechanism as
phosphorylation by [γ-32P]ATP would be expected to be absent or highly reduced when
the functional side chain of His533 was eliminated. This result warrants further analysis
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in order to determine whether the mechanism indeed proceeds through a second
phosphoenzyme intermediate.
The ckcACDI structure co-crystallized with the non-hydrolyzable ATP analog
AMPPCP has the catalytic Hisα residue oriented toward the beta subunit (21). Weiße et
al. (21) indicate that this structure supports the four-step reaction mechanism proposed
by Brasen et al. (20) because the distance is too great for direct transfer of the
phosphate group between Hisα and ATP. The distances they use to draw this
conclusion are between AMPCP, an ADP analog, and the two His residues. They are
reported as 8.7 Å between AMPCP and His254α, 6.7 Å between AMPCP and
His68β, and 7.1 Å between His254α and His68β.
However, these do not accurately represent the distance for phosphate transfer.
Instead, we measured the distance between the terminal phosphate of AMPPCP, an
ATP analog, and the N3 position of the imidazole ring of His254α and found it to be just
5.7 Å, shorter than the distances for phosphoryl transfer from ATP to Hisβ (7.9 Å) and
then to His254α (9.0 Å) (FIG 3.4). Distances were also calculated for the alternative N1
position of His68β and these too were greater than the direct distance between
AMPPCP and His254α (8.5 Å to His254α and 6.2 Å to the terminal phosphate group of
AMPPCP). Thus, direct phosphorylation of His254α by ATP is more likely than
phosphorylation of His68β followed by transfer to His254α, consistent with a three-step
mechanism as for SCS rather than a four-step mechanism.
An interesting phenomenon in ACL may explain the additional phosphorylation
observed in PfACD (20). Isotopic labeling revealed that low levels of phosphorylation
occur in Chlorobium limicola ACL after long periods of time when the catalytic Hisα was
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altered. This group suggested that a second unproductive phosphorylation site may be
present within the active site. This phenomenon may hold true for at least some ACDs
as well.
Conclusion
We have demonstrated the importance of four residues involved in catalysis of E.
histolytica ACD and their contributions to phosphorylation of the enzyme. We propose
that EhACD follows a three-step mechanism analogous to that of SCS rather than the
four-step mechanism involving two phosphoenzyme intermediates as proposed by
Brasen et al. (20); however, more direct evidence related to the mechanism is needed.
The dimeric EhACD has fused alpha and beta domains, resulting in a different subunit
structure than PfACD and ckcACDI, both of which are heterotetramers with separate
alpha and beta subunits. As a result, ACDs may fall into two classes based on subunit
structure, one of which can directly transfer the phosphate group between Hisα and ATP
and the other of which relies on a two-step transfer to bridge that distance.
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FIG 3.4 Distance measurements in Site II of ckcACDI. The ckcACDI structure
crystallized with CoA and MgAMPPCP with Hisα in Site II of the active site was obtained
from PDB (accession #4XZ3). His254α is shown in purple and His68β is shown in blue.
MgAMPPCP is colored by element: C (gray), P (orange), O (red), N (purple), H (light
gray), and Mg (green). The distance between N3 of Hisα and P of AMPPCP (yellow line)
is 5.7 Å. The distances between Hisα and Hisβ (orange line) and between Hisβ and P of
AMPPCP (green line) are 9 Å and 7.9 Å, respectively.
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CHAPTER 4

PROBING THE FUNCTION OF ADDITIONAL RESIDUES WITHIN ADP-FORMING
ACETYL-COA SYNTHETASE OF ENTAMOEBA HISTOLYTICA USING
COMPUTATIONAL MODELING AND SITE-DIRECTED MUTAGENESIS

Cheryl Jones, Noah Smith, and Cheryl Ingram-Smith

I.

ABSTRACT

The ADP-forming acetyl-CoA synthetase (ACD) from Entamoeba histolytica
belongs to the NDP-forming acyl-CoA synthetase superfamily. Interest in this family of
enzymes has increased due to their role in the central carbon metabolism of almost all
organisms. The most well-studied enzyme of this family is succinyl-CoA synthetase from
Escherichia coli. However, structural characterization of ACD from Candidatus
Korarchaeum cryptofilum has added great insight into ACD function. In order to probe
the functional role of proposed active site residues of the E. histolytica ACD, site-altered
variants were produced for Gln159, Lys534, and Asp314. Characterization, along with
computational modeling of these residues, gives evidence regarding their potential
significance.
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II.

INTRODUCTION

ADP-forming acetyl-CoA synthetase (ACD; EC 6.2.1.13) is an acetate thiokinase
that catalyzes the reversible conversion of acetate to acetyl-CoA. ACD was first
identified in Entamoeba histolytica extracts in 1977 (1) and was later recombinantly
produced, purified, and characterized (2). Investigation into the catalytic mechanism of
E. histolytica ACD has confirmed the importance of the primary catalytic Hisα residue (C.
Jones, K. Khan, and C. Ingram Smith, in preparation). Crystal structures of the separate
alpha and beta subunits from Pyrococcus horikoshii (accession numbers 1WR2 and
2CSU) were solved in 2005 but gave incomplete information regarding the quaternary
structure of ACD. Recent structural characterization of ACDI from Candidatus
Korarchaeum cryptofilum revealed insight into the tertiary and quaternary structure (3).
ACD contains two distinct locations of the active site, designated Site I and Site II (3).
Acetyl-CoA and Pi bind to the enzyme in Site I, forming a transient acetyl-phosphate
bound intermediate, and releasing CoA. The phosphoryl moiety is then transferred to N3
of the imidazole ring on the catalytic His residue located on the phosphohistidine loop of
Site I. It was previously postulated that this loop then swings to site II to transfer this
phosphoryl group to ADP to form ATP. Analysis of the Ca. K. cryptofilum structure
revealed that an α-helix of the phosphohistidine loop partially unravels in order to “swing”
to Site II (3). The NDP substrate bound within Site II is then phosphorylated, returning
the enzyme to its normal state.
Some NDP-forming acyl-CoA synthetases directly phosphorylate the NDP
substrate. However, Brasen et al. (4) proposed that ACD requires an additional
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phosphoryl transfer step involving a second His residue, utilizing the following four-step
mechanism:
Step 1:

E + acetyl-CoA + Pi ßà E~acetyl-P + CoA

Step 2:

E~acetyl-P ßà E~Hisα-P

Step 3:

E~Hisα-P ßà E~Hisβ-P

Step 4:

E~Hisβ-P + ADP ßà E + ATP

Crystal structures of Ca. K. cryptofilum solved in the presence of various ligands
demonstrated the Hisα residue phosphorylated in both Site I and Site II; however, a
structure in which the Hisβ residue was phosphorylated was not obtained (3).
Characterization of Hisβ variants has shown this residue to be important for catalysis (4),
but our results suggest that it is not essential (C. Jones, K. Khan, and C. Ingram-Smith,
in preparation).
Other enzymes within the NDP-forming acyl-CoA synthetase superfamily have
been structurally characterized, including human ATP-citrate lyase (ACL) (5,6), and
succinyl-CoA synthetase (SCS) from Escherichia coli (7-11), pig heart (12-14), and
Thermus aquaticus (15,16). The significant shuffling of domains within this family poses
a challenge in comparing structural data from one enzyme to another. Yet, the
increasing number of structures available signifies that we are working toward a deeper
understanding of the common and defining features between enzymes in this family.
Here we continue to investigate the role of additional residues in E. histolytica
ACD (EhACD) and construct a homology model based on the recently solved Ca. K.
cryptofilum ACD (ckcACD) structure.
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III.

MATERIALS AND METHODS

Materials
Chemicals were purchased from Sigma Aldrich, Gold Biotechnology, Fisher
Scientific, or VWR. Oligonucleotide primers were purchased from Integrated DNA
Technologies, Inc.
Sequence Alignment
Amino acid sequences annotated as ADP-forming acetyl-CoA synthetases were
acquired from NCBI and additional sequences were identified using PSI-BLAST
(http://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins) (17) with the E. histolytica ACD
sequence (GI: 67481881) as the query. The multiple sequence alignment was
constructed using ClustalOmega (http://www.ebi.ac.uk/Tools/msa/clustalo/) (18).
Site-directed mutagenesis
The codon-optimized E. histolytica acd gene, cloned into pET21b which provides
for an addition of a C-terminal 6xHis tag, was subjected to site-directed mutagenesis
using the QuikChange II kit (Agilent Technologies, Inc.). Mutagenesis primers used are
as follows: Gln159Asp, (F) GTGGCCTTCATCTCTGACAGTGGCGCACTGTGT and (R)
ACACAGTGCGCCACTGTCAGAGATGAAGGCCAC; Asp314Ala, (F)
CCGGGTGTGATTAGTACGGCTCGCCTGGTTAGCGTTCATG and (R)
CATGAACGCTAACCAGGCGAGCCGTACTAATCACACCCGG; Lys534Arg, (F)
GAGTCCGGATATTATGCATCGAACCGATGTTGGCGG and (R)
CCGCCAACATCGGTTCGATGCATAATATCCGGACTC. The His533Ala Lys534Arg
variant was constructed using the mutagenized EhACD His533Ala pET21b plasmid and
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the following primers: (F) GAGTCCGGATATTATTGGCTCGAACCGATGTTGGCGG and
(R) CCGCCAACATCGGTTCGAGCCATAATATCCGGACTC. Mutagenesis was
confirmed via DNA sequencing (Clemson University Genomics Institute).
Production of EhACD variants
E. coli Rosetta2 (DE3) pLysS cells (EMD) carrying pET21b containing the
mutated acd gene were grown in LB medium to an optical density of 0.6 at 600 nm. ACD
protein production was induced by adding IPTG to a final concentration of 1 mM, and
cells were grown overnight shaking at 200 rpm at room temperature. Cells were
harvested by centrifugation and EhACD was purified by nickel affinity chromatography
as described previously (2).
Enzyme assays
EhACD activity was determined in the acetyl-CoA forming direction using the
hydroxamate assay (2,19). Initial activity assays were conducted at 37°C using the
saturating substrate concentrations determined for the wild-type enzyme (2): 50 mM
Tris-HCl pH 7.3, 300 mM hydroxylamine pH 7.0, 20 mM MgCl2-ATP, 1 mM CoA, and
100 mM sodium acetate. The reaction volume was 150 µl and reactions were terminated
by the addition of an equal volume of a solution containing 2.5% FeCl3 and 10%
trichloroacetic acid in 2N HCl. Saturating substrate concentrations for Gln159Glu were
450 mM sodium acetate, 1 mM CoA, 40 mM MgCl2, and 15 mM ATP. Assays for kinetic
characterization of Gln159Glu were carried out for 30 minutes at 37°C. Kinetic
parameters were determined as previously described (2), using non-linear regression
(Kaleidagraph, Synergy software).
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Generation of homology models
The Ca. K. cryptofilum ACDI is a heterotetramer of two alpha and two beta
chains (3). Since EhACD is a dimer in which the subunits represent a fusion of the alpha
and beta domains, two chains were used to align the sequences and generate homology
models based on the Ca. K. cryptofilum template structures using Accelrys Discovery
Studio 3.5 software. Three models were generated based on different conformations of
the catalytic residues. For each, the model with the lowest DOPE (discreet optimized
protein energy) score was selected for further analysis. Model 1, based on Ca. K.
cryptofilum 4YBZ, shows ACD complexed with ADP and the catalytic Hisα at Site 1.
Model 2, based on Ca. K. cryptofilum 4YYM, shows ACD in complex with coenzyme A,
Ca-AMPCP (ADP analog) and HgCl+, and the Hisα is positioned near Site I. Model 3 is
based on Ca. K. cryptofilum 4XZ3 and shows ACD in complex with CoA and MgAMPPCP (ATP analog) and the phosphorylated Hisα in Site II. In silico analysis of
Asp314Ala and Asp314Glu alterations was performed by altering the residue within the
sequence of both chains and subsequently building a homology model based on 4XYM.
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IV.

RESULTS

Gln159, conserved in ACD sequences (FIG 4.1A) but replaced by Arg in other
family members such as SCS, ACL, and malyl-CoA synthetase (MCS) (20), is predicted
to interact with the phosphohistidine loop based on the function of the Arg residue in E.
coli SCS (11). Altering this Gln to a Glu substantially decreased activity to approximately
8% that of the wild-type enzyme (FIG 4.1B). Kinetic characterization of the Gln159Glu
variant revealed a 13-fold decrease in kcat (TABLE 4.1). The Km values for CoA and ATP
showed only minor changes compared to wild-type, but the Km for acetate increased 6fold.
The catalytically important His533 and the adjacent Lys534 are conserved in
ACD, pimeloyl-CoA synthetase, acetyltransferases, and several predicted acyl-CoA
synthetases (20). However His533 is homologous to an Arg and Lys534 is homologous
to a Gly residue in SCS, MCS, and ACL. A Lys534Arg variant and a His533Ala
Lys534Arg double variant were generated and analyzed. The double variant had little to
no activity (<0.5%), however the Lys534Arg variant retained ~12% activity (FIG 4.2).
Homology models of E. histolytica ACD were generated based on structures from
Ca. K. cryptofilum (FIG 4.3). EhACD, which is a homodimer (2), shares 37% identity with
ckcACD, a heterotetramer (3). There are two active sites within ACD; the
phosphohistidine loop containing His252α is capable of changing conformation to
occupy either Site I (FIG 4.4 and 4.5) or Site II (FIG 4.6A). Site II is the location of the
ADP/ATP binding site and His533β (FIG 4.6B). As seen in Figure 4.6C, Lys534 is
oriented on the opposite side of His533.
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Asp314, conserved among all known NDP-forming acyl-CoA synthetases (20), is
predicted to interact with the phosphohistidine loop (7), but was also demonstrated to
play a role in oligomer formation in E. coli SCS (21). Attempts to produce the Asp314Ala
variant were unsuccessful. Therefore, in silico analysis was used to attempt to
understand whether Asp314 contributes to the structural integrity of the enzyme. Asp314
is located within an α-helix near the catalytic His residue (FIG 4.7A), and participates in
hydrogen bonds between the two chains (example shown in FIG 4.7B). Hydrogen
bonding occurred at the interface of the two monomers between Asp314 on one chain
and residues 240-242 on the opposite chain. In all models generated, Asp314 was
responsible for three out of ten total intermolecular hydrogen bonds between the
monomers. Asp314Ala and Asp314Glu alterations were generated in silico and revealed
that Asp314Glu was capable of hydrogen bonding in a similar fashion (FIG 4.7D), while
Asp314Ala lost the ability (FIG 4.7C). Loss of this bonding may prevent oligomerization,
which subsequently affects stability.
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FIG 4.1 EhACD Gln159. (A) Sequence alignment of Gln159 in ACDs. (B) Activity of
Gln159Asp variant compared to wild-type in the acetyl-CoA forming direction.
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TABLE 4.1 Kinetic parameters for the Gln159Glu variant in the acetyl-CoA forming
direction.

Substrate

Enz

Km
(mM)

Fold
change

kcat
(sec-1)

Fold
change

Acetate

WT
Q159E

14 ± 0.6
89 ± 9

+6.4x

233 ± 2.7
18 ± 0.5

-13x

CoA

WT
Q159E

0.20 ± 0.01
0.16 ± 0.01

-1.3x

328 ± 5
24 ± 0.3

-14x

ATP

WT
Q159E

12 ± 0.4
4.1 ± 0.2

-2.9x

320 ± 4
22 ± 0.01

-15x
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FIG 4.2 Activity of Lys534 variants in the acetyl-CoA forming direction.
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A

B

FIG 4.3 Ribbon diagram of EhACD homology model based on 4YBZ. (A) Top view
(B) Front view. Chain A is shown in green and Chain B in blue.
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FIG 4.4 Active sites of EhACD with the phosphohistidine loop pointed toward Site
I. Homology model of EhACD based on 4XYM. The phosphohistidine loop of Chain A is
colored in pink and the phosphohistidine loop of Chain B is colored in blue. The position
of the two active sites of Chain A are as designated.
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FIG 4.5 Targets of site-directed mutagenesis. Within Site I: Gln159 (light blue),
Glu213 (yellow), His252 (red), Asp314 (purple). Within Site II: His533 (orange), Lys534
(green), Asp674 (dark blue).
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FIG 4.6 Homology model of EhACD with the phosphohistidine loop pointed toward
Site II. This structure was modeled based on 4XZ3, which includes CoA and AMPPCP
as ligands. (A) Ribbon diagram of the dimer with the phosphohistidine loops shown in
pink (chain A) and blue (chain B). (B) Proximity of His252α (pink) and His533β (purple)
to the AMPPCP ligand. (C) Lys534 (blue) has an orientation opposite of His533β
(purple).
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FIG 4.7 In silico analysis of Asp314. Chain A is shown in green and Chain B is shown
in blue. (A) Asp314 of Chain B is part of an α-helix located parallel to an α-helix of the
phosphohistidine loop of Chain A. His252 (green) and Asp314 (orange) are shown in ball
and stick model. (B) Asp314 (orange) is predicted to hydrogen bond with a side chain O
of Ser242 (yellow) and a main chain N of Gly240 (pink) on the opposite chain. Hydrogen
bonds are indicated by dotted green lines. (C) In silico analysis of alteration of Asp314 to
Ala shows a loss of intermolecular hydrogen bonding, whereas (D) Asp314Glu is
predicted to hydrogen bond with Gly240 (pink) and Lys241 (purple).
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V.

DISCUSSION

Gln159 is located within a set of conserved residues [Ser-Gln-Ser-Gly-Ala] that
reside in Site I. These residues are near the acetyl-CoA/acetate binding pocket and are
part of an α-helix. This helix is one of two helices designated by Fraser et al. (8) as
power helix 1 and power helix 2 due to their role in the coordination of the
phosphorylated histidine. The Gly-Ala residues of this motif in power helix 1 are thought
to interact with the acetyl moiety of acetyl-CoA (3). Given the proximity of Gln159 to the
acetate binding pocket as well as the increased Km for acetate, we hypothesize that
alteration of Gln159 disrupts acetate binding or coordination. However, replacing Gln
with the negatively charged Glu may also disrupt power helix 1, causing inefficient
catalysis. Further characterization with additional variants such as Gln159Ala and
Gln159Asn could provide additional insight regarding the function of this residue.
Although E. histolytica ACD consists of fused alpha and beta subunits, the hinge
region connecting the subunits is very short. Consequently, homology modeling based
on the heterotetrameric structure resulted in significant overlap with very few diverging
residues. In contrast to SCS, a single active site of ACD consists of residues from both
chains, demonstrating the necessity for dimer formation. However, it remains unclear if
the active sites can function simultaneously or have any affect on one another.
Before structural information was available, we hypothesized that alteration of
Lys534 could potentially compensate for the reduced activity observed in His533
variants (C. Jones, K. Khan, C. Ingram-Smith, in preparation). These adjacent residues
share the same pattern of conservation within the enzyme superfamily. The Arg-Gly
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residues in SCS and the corresponding His-Lys residues of ACD could potentially result
in a positively charged environment. The reduced activity of the Lys534Arg variant
indicates that this residue is necessary for maximal catalysis but that the positive charge
alone is not sufficient, and that appropriate side chain length is also important. Homology
modeling revealed that the side chain of Lys534 has an orientation opposite that of
His533. This suggests that Lys534 is unable to compensate for the lack of His533 in
providing the positive charge environment needed. However, the corresponding Lys69β
residue in ckcACDI was shown to interact with the ADP substrate by both the side-chain
amine and the backbone nitrogen. Kinetic analysis should be performed in order to
determine if the absence of Lys534 affects the Km of ADP as a substrate.
Asp314 is located at the interface of the two monomers of ACD and participates
in hydrogen bonding with residues on the opposite chain. After repeated failed attempts
at production and purification, we hypothesized that alterations of this residue may result
in an unstable protein product. Structural modeling supports this theory, as in silico
alteration of Asp314 to Ala resulted in disruption of intermolecular hydrogen bonding,
potentially preventing proper oligomerization.
In summary, the new structural information available for ACD provides a basis for
understanding the function and mechanism of this enzyme. Multiple residues were
identified to influence activity or structure, including Gln159 and Asp314 of the alpha
subunit and Lys534 of the beta subunit. However, a crystal structure of the fused alphabeta enzyme of E. histolytica would be useful in the future.

135

VI.

ACKNOWLEDGEMENTS

We thank Dr. Kerry Smith (Clemson University) for helpful insight on this project. This
work was supported by NSF award 0920274, an NSF Graduate Research Fellowship to
CJ, Clemson University Creative Inquiry, and Clemson University.

136

VII.

REFERENCES

1.

Reeves, R. E., Warren, L. G., Susskind, B., and Lo, H. S. (1977) An energyconserving pyruvate-to-acetate pathway in Entamoeba histolytica. Pyruvate
synthase and a new acetate thiokinase. J Biol Chem 252, 726-731

2.

Jones, C. P., and Ingram-Smith, C. (2014) Biochemical and kinetic
characterization of the recombinant ADP-forming acetyl coenzyme A synthetase
from the amitochondriate protozoan Entamoeba histolytica. Eukaryot Cell 13,
1530-1537

3.

Weiße, R. H., Faust, A., Schmidt, M., Schonheit, P., and Scheidig, A. J. (2016)
Structure of NDP-forming Acetyl-CoA synthetase ACD1 reveals a large
rearrangement for phosphoryl transfer. Proc Natl Acad Sci U S A 113, E519-528

4.

Brasen, C., Schmidt, M., Grotzinger, J., and Schonheit, P. (2008) Reaction
mechanism and structural model of ADP-forming Acetyl-CoA synthetase from the
hyperthermophilic archaeon Pyrococcus furiosus: evidence for a second active
site histidine residue. J Biol Chem 283, 15409-15418

5.

Sun, T., Hayakawa, K., Bateman, K. S., and Fraser, M. E. (2010) Identification of
the citrate-binding site of human ATP-citrate lyase using X-ray crystallography. J
Biol Chem 285, 27418-27428

6.

Sun, T., Hayakawa, K., and Fraser, M. E. (2011) ADP-Mg2+ bound to the ATPgrasp domain of ATP-citrate lyase. Acta Crystallogr Sect F Struct Biol Cryst
Commun 67, 1168-1172

7.

Fraser, M. E., James, M. N., Bridger, W. A., and Wolodko, W. T. (1999) A
detailed structural description of Escherichia coli succinyl-CoA synthetase. J Mol
Biol 285, 1633-1653

8.

Fraser, M. E., Joyce, M. A., Ryan, D. G., and Wolodko, W. T. (2002) Two
glutamate residues, Glu 208 alpha and Glu 197 beta, are crucial for
phosphorylation and dephosphorylation of the active-site histidine residue in
succinyl-CoA synthetase. Biochemistry 41, 537-546

9.

Joyce, M. A., Fraser, M. E., Brownie, E. R., James, M. N., Bridger, W. A., and
Wolodko, W. T. (1999) Probing the nucleotide-binding site of Escherichia coli
succinyl-CoA synthetase. Biochemistry 38, 7273-7283

10.

Joyce, M. A., Fraser, M. E., James, M. N., Bridger, W. A., and Wolodko, W. T.
(2000) ADP-binding site of Escherichia coli succinyl-CoA synthetase revealed by
x-ray crystallography. Biochemistry 39, 17-25

137

11.

Wolodko, W. T., Fraser, M. E., James, M. N., and Bridger, W. A. (1994) The
crystal structure of succinyl-CoA synthetase from Escherichia coli at 2.5-A
resolution. J Biol Chem 269, 10883-10890

12.

Fraser, M. E., Hayakawa, K., Hume, M. S., Ryan, D. G., and Brownie, E. R.
(2006) Interactions of GTP with the ATP-grasp domain of GTP-specific succinylCoA synthetase. J Biol Chem 281, 11058-11065

13.

Fraser, M. E., James, M. N., Bridger, W. A., and Wolodko, W. T. (2000)
Phosphorylated and dephosphorylated structures of pig heart, GTP-specific
succinyl-CoA synthetase. J Mol Biol 299, 1325-1339

14.

Huang, J., Malhi, M., Deneke, J., and Fraser, M. E. (2015) Structure of GTPspecific succinyl-CoA synthetase in complex with CoA. Acta Crystallogr F Struct
Biol Commun 71, 1067-1071

15.

Joyce, M. A., Brownie, E. R., Hayakawa, K., and Fraser, M. E. (2007) Cloning,
expression, purification, crystallization and preliminary X-ray analysis of Thermus
aquaticus succinyl-CoA synthetase. Acta Crystallogr Sect F Struct Biol Cryst
Commun 63, 399-402

16.

Joyce, M. A., Hayakawa, K., Wolodko, W. T., and Fraser, M. E. (2012)
Biochemical and structural characterization of the GTP-preferring succinyl-CoA
synthetase from Thermus aquaticus. Acta Crystallogr D Biol Crystallogr 68, 751762

17.

Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W.,
and Lipman, D. J. (1997) Gapped BLAST and PSI-BLAST: a new generation of
protein database search programs. Nucleic Acids Res 25, 3389-3402

18.

Sievers, F., Wilm, A., Dineen, D., Gibson, T. J., Karplus, K., Li, W., Lopez, R.,
McWilliam, H., Remmert, M., Soding, J., Thompson, J. D., and Higgins, D. G.
(2011) Fast, scalable generation of high-quality protein multiple sequence
alignments using Clustal Omega. Mol Syst Biol 7, 539

19.

Lipmann, F. T., C. T. . (1945) A specific micromethod for the determination of
acyl phosphates. J Biol Chem 159, 21-28

20.

Sanchez, L. B., Galperin, M. Y., and Muller, M. (2000) Acetyl-CoA synthetase
from the amitochondriate eukaryote Giardia lamblia belongs to the newly
recognized superfamily of acyl-CoA synthetases (Nucleoside diphosphateforming). J Biol Chem 275, 5794-5803

21.

Binieda, A., Fuhrmann, M., Lehner, B., Rey-Berthod, C., Frutiger-Hughes, S.,
Hughes, G., and Shaw, N. M. (1999) Purification, characterization, DNA
sequence and cloning of a pimeloyl-CoA synthetase from Pseudomonas
mendocina 35. Biochem J 340 ( Pt 3), 793-801

138

CHAPTER 5

CONCLUSIONS AND FUTURE WORKS

ACD’s role in cellular metabolism
ADP-forming acetyl-CoA synthetase is responsible for the interconversion of
acetyl-CoA and acetate coupled to the formation of ATP. This is an energy conserving
reaction that exchanges one high-energy bond for another. The amitochondriate
parasite Entamoeba histolytica lacks many typical eukaryotic metabolic pathways,
making the conservation of energy especially important. Thus, we believe that ACD
could be important for maintaining energy homeostasis in E. histolytica under the varying
conditions it encounters.
Pineda et al. (1) demonstrated that ACD is responsible for acetate production by
E. histolytica during growth on glucose in vitro and theorized that it functions to recycle
CoA. Although they found that ACD’s contribution to the ATP pool was not significant
during in vitro growth, the nutrient environment surrounding the cell differs greatly when
inside the host compared to the controlled environment in culture. Thus, these in vitro
results may not be truly representative of ACD’s role in ATP production.
As our results have shown that ACD is subject to inhibition by ATP in the
acetate-forming direction of the reaction (2), ACD function in the cell is likely regulated
by the AMP:ATP ratio. If ATP levels drop and AMP levels rise, ACD is capable of
producing additional ATP for the cell and concomitantly producing acetate (FIG 5.1A). In
addition, if acetyl-CoA levels are in excess, they can be shuttled through ACD as a type
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of overflow metabolism in order to recycle CoA and conserve energy through ATP
production (FIG 5.1B). When ATP is plentiful, excess ATP could then be redirected
towards activation of acetate in order to utilize this potential carbon source (FIG 5.1C).
This would be particularly useful within the acidic microenvironment of the colon where
the concentration of short-chain fatty acids such as acetate and propionate are high, and
these compounds can diffuse through the membrane. When acetic acid enters the cell in
its protonated form, it quickly dissociates into acetate and a proton at the neutral
intracellular pH. As this could be toxic to the cell, activation by ACD would serve as a
method of detoxifying acetate and maintaining intracellular pH (FIG 5.1D).
ACD may also function in activating acetate that is produced from endogenous
sources. Cysteine has been determined to be essential for its redox capacity in E.
histolytica (3) and consequently, the cysteine synthesis pathway has been maintained.
Cysteine synthesis occurs through acetylation of serine and release of acetate when the
sulfide group is added. ACD could theoretically function in a loop to recycle the acetate
into another acetyl-CoA molecule to refuel cysteine synthesis (FIG 5.1E).
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FIG 5.1 EhACD may function as a reversible enzyme in response to the cell’s
needs. Acetate is represented by orange pentagons, ATP by green ovals, ADP by
purple ovals, and AMP by pink ovals. (A) Under low ATP concentrations, ACD can
function in the acetate-forming direction and supplement ATP levels. (B) When acetylCoA is in excess, ACD could function in the acetate-forming direction as a type of
overflow metabolism. (C) When ATP concentrations are high, ACD is inhibited in the
acetate-forming direction and would instead use the excess ATP to activate acetate to
acetyl-CoA. (D) Exogenous acetate may diffuse into the cell or be taken in by fluid-phase
endocytosis. When acetate is in excess, ACD can negate its potentially toxic effects by
converting it to acetyl-CoA. (E) ACD could also function by using endogenous sources of
acetate, such as from cysteine synthesis.
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These assumptions are based on characterization of the recombinant enzyme (2)
and therefore further experimental evidence is needed to fully explore the role of ACD
within E. histolytica. These possible scenarios can be investigated by changing culture
media conditions (pH, acetate concentrations, etc.) and comparing wild-type and ACD
knockdown cell lines.
Enzymatic mechanism
Based on the characterization of site-altered variants and isotopic labeling by
phosphorylation, we hypothesize that ACD proceeds through a three-step mechanism
similar to that for succinyl-CoA synthetase (FIG 5.2). Acetyl-CoA and Pi bind within Site I
and form a transient acetyl phosphate intermediate. This intermediate phosphorylates
the Hisα residue within Site I. Crystal structures of ACD were obtained with Hisα
phosphorylated in Site I (4), suggesting a binding event or release of CoA may be
required for the conformational change of the phosphohistidine loop to occur. One
possibility is that upon ADP binding, the phosphorylated Hisα moves into position within
Site II and phosphorylates ADP to form ATP. The opposite reaction also takes place.
ATP binds within Site II and causes Hisα to move into Site II where it becomes
phosphorylated. Then Hisα-P moves back to Site I where it can transfer the phosphoryl
group to acetate. Acetyl phosphate then acetylates CoA and releases phosphate.
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FIG 5.2 Schematic of the proposed three-step ACD mechanism. Green ovals
represent Site I and blue ovals represent Site II. The transferred phosphate group is
shown as a purple triangle.
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Glu213 is required for stable phosphorylation of Hisα by the acetyl phosphate
intermediate within Site I to occur. However, isotopic labeling revealed His252 may be
phosphorylated within Site II when Glu213 is absent, so it is not necessary for ATP
phosphorylation of Hisα. This variant could be a useful tool for determining the crystal
structure of ACD with a phosphorylated Hisα in Site II. The absence of His533 does not
prevent phosphorylation from occurring in either direction, challenging the four-step
reaction proposed by Brasen et al. (5) in which His533 is directly phosphorylated during
the catalysis.
Asp674 is important for optimal phosphorylation to occur, and based on the
homologous residue within ckcACDI (4), is thought to help stabilize Hisα when located in
Site II. Asp314 located within power helix 1, is likely important for the structural integrity
of the enzyme. Lys534 alteration resulted in reduced activity, and this residue is
postulated to bind the ADP/ATP substrate. Kinetic characterization of Gln159Glu
suggests a role for this residue in acetate binding or coordination. Future structural
analysis using the recently generated model combined with kinetic characterization will
enhance our understanding of the function and mechanism of this enzyme. In addition,
an EhACD crystal structure is in the final stages of refinement (S. Swaminathan,
personal communication) and will allow direct analysis of the active sites of the
homodimeric EhACD and comparison to the heterotetrameric archaeal ACDs.
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